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1.1. Insulin-like growth factor and insulin receptor signaling 
 
The insulin-like growth factor (IGF) signaling (Fig.1) is known to have an essential role in the 
normal growth and development of the central nervous system (CNS). IGF signaling 
possesses pleiotropic effects on all major neural cell types, as well as neural stem cells 
(NSCs), post-mitotic neurons, oligodendrocytes and astrocytes. IGF-I and IGF-II are able, by 
interacting with the type 1 IGF receptor (IGF1R) to promote proliferation, maturation, survival 
as well as growth of neural cells. Furthermore there is evidence that IGF signaling is able to 
influence specific biological processes by modulating neural signals. This can facilitate 
primary instructive signals to steer NSC in the direction of a specific cell lineage during early 
development [O'Kusky and  Ye, 2012; Broughton and Partridge, 2009]. 
The IGF system consists of IGF-I, IGF-II, the IGF1R, the type 2 IGF receptor (IGF2R), and 
the IGF binding proteins (IGFBPs). Growth promoting actions of the IGFs are for the most 
part mediated by the IGF1R. Receptor binding and biological activities are regulated by 
IGFBPs. Here at least 10 IGFBPs, where six are high-affinity and four low-affinity IGFBPs, 
are known. Both IGFs are able to bind at high concentrations to the insulin receptor (InR). 
Especially the InR is competent to mediate IGF-II actions [Louvi et al., 1997; Morrione et al., 
1997]. 
 
 
 
Figure 1: IGF signaling in the brain 
IGF signaling pathways in the CNS are schematically pictured. Signaling molecules and pathways in non-
neuronal cells are not shown. ┴ = inhibitory modification, and ↓ = stimulatory modification [O'Kusky and Ye, 2012] 
 
1. Introduction   
 
  3 
1.1.1. The insulin receptor 
 
The InR, with more than 150 kilobases in length containing 22 exons and 21 introns and is 
located on the short arm of the human chromosom 19 [Seino and Bell, 1990]. It consists of 
two α-subunits which are both linked to a β-subunit and to each other via disulfide bonds 
(Fig.2) [Seino and Bell, 1990]. There are two different isoforms present due to alternative 
splicing of exon 11 which encodes for 12 amino acids (aa). The first isoform A lacks those 12 
aa while isoform B contains those. In contrast the IGF1R gene possesses no equivalent to 
exon 11, therefore no alternative splicing has been described, yet. Both isoforms of the InR 
are able to bind with the same affinity to insulin [McClain, 1991]. Alongside isoform A reveals 
a higher affinity to IGFs than isoform B [Yamaguchi et al., 1991; Frasca et al., 1999]. Isoform 
A is mainly expressed in fetal tissue, hematopoietic cells and in the adult nervous system, 
isoform B predominatly is found in adipose tissue, muscle and liver [Seino and Bell 1989; 
Moller et al., 1989; Goldstein and Kahn, 1989; Mosthaf et al., 1990]. 
 
Figure 2: Schematic diagram of the insulin receptor tretramer 
The cell membrane is pictured as a horizontal line. The insulin binding sites are presented in the α-subunit, and 
the autophosphorylation sites are numerated in the β-subunuits. [White, 1997] 
 
As the α-subunits are entirely located outside of the cell and comprise the side for insulin 
binding. The β-subunits include an extracellular, a transmembrane and an intracellular 
domain containing the insulin-regulated tyrosine protein kinase. There are two other 
structurally related molecules, which belong to the insulin receptor family, the IGF1R and the 
insulin receptor-related (IRR) receptor, which is an orphan receptor for which, no ligand has 
yet been indentified [Shier and Watt, 1989].   
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1.1.2. The IGF1R and IGF2R 
 
The IGF1R was discovered later than the InR (1974), which tyrosine activity was found in 
1982 [Megyesi et al., 1974; Kasuga et al., 1982; Kasuga et al. 1982], and then as well 
classified as a receptor tyrosine kinase [Megyesi et al., 1974; Jacobs et al., 1983; Rubin et 
al., 1983]. Also the IGF1R is ubiquitously expressed in all neural cell types (also neural stem 
cells and neural precursor cells) [Popken, Dechert-Zeger, Ye and D’Ercole, 2005]. The 
abundance of the IGF1R is corellated to cell proliferation and growth [O'Kusky and Ye, 2012; 
Zhang, Moats-Staats, Ye and D’Ercole, 2007]. 
As the InR, the IGF1R is a heterotetrameric glycoprotein which, is linked by disulfide bounds 
α- and β-subunits. The 135kDa α-subunits are located outside the cell and are able to bind 
IGFs [Van Obberghen et al., 1981; Ullrich et al., 1986]. The β-subunits with a size of 95kDa 
consist of a long intracytoplasmic domain which contains intrinsic tyrosine kinase activity as 
well as critical tyrosine and serine residues. As the IGF1R has a 46% homology with the InR, 
both receptors can form hybrid receptors. To form those they use the α- or β- subunits of 
each other. IGF1R/InR hybrids remain capable to transduce both IGF and/ or insulin 
signaling, even though the exact functional significance is still unkown. Dependent on the 
assembly of InR or IGF1R, different affinities of binding to insulin or IGF-I occur [Pandini et 
al., 2002]. Whereas IGF-II and insulin are bound to the hybrid of IGF1R and the isoform A of 
the InR with similar affinity, the hybrid of IGF1R and isoform B is only capable to bind IGFs 
[Louvi, Accili, and Efstratiadis, 1997]. 
Binding of IGF-I to the α-subunit of the IGF1R triggers a conformation change leading to 
autophosphorylation of the β-subunit at Tyr1131, 1135 and 1136. This stimulates signaling 
cascades which result in phosphorylation of a variety of intracellular substrate proteins 
[LeRoith et al. 1995] for instance insulin receptor substrate (IRS) -1 and 2. The same 
happens to the InR, here are the autophosphorylation sides Tyr 1146, 1150 and 1151 [Kahn 
et al., 1978; Kasuga et al., 1982; Chou et al., 1987; White, 1998]. 
The IGF2R is in contrast a single chain transmembrane protein. It’s construction is identical 
to the cation-independent mannose-6-phosphate receptor and works to translocate proteins 
which contain mannose-6-phosphate motives and IGF-II to lysosomes for their degradation. 
Intrinsic enzymatic activity for the intracellular domain of the IGF2R has not been observed. 
Besides that there is evidence, that it interacts with IGF-I and that it might mediate partially 
IGF growth promoting activity in the brain [O'Kusky and Ye, 2012]. Additionally IGF-II has a 
growth- promoting function during mouse embryogenesis, which is partly mediated by 
signaling through the InR [Efstratiadis et al., 1997]. 
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Figure 3: The InR and IGF1R family 
Shown are the two splice variant isoforms of InR (InRa and InRb) and the IGF1R. Those can dimerize to form six 
receptor species, which vary in their ligand affinitiy. Insulin circulates in lower concentrations than IGFs, but has 
direct access to target tissues. Whereas IGFs can be bound by IGFBPs and therefore cannot reach the receptor. 
Or as IGFII through IGF2R, which targets the ligand for degradation without signal transduction. [Pollak, 2012] 
 
1.1.3. IGF binding proteins 
 
At least 10 IGFBPs, where six are high-affinity and four are low-affinity IGFBPs, are known. 
IGF-I and IGF-II which are circulating and found in the extracellular space of most tissues are 
almost completely bound by the IGFBPs. The high affinity IGFBPs are represented by 
IGFBP-1 to IGFBP-6. These share their structural homology and bind specifically to IGF-I 
and IGF-II [Jones and Clemmons, 1995]. Through this interaction they are either able to 
attenuate (mostly IGFBP-4 and -6) or increase (mainly IGFBP-3 and -5) binding of IGF-I to its 
receptor [Rajaram, Baylink and Mohan, 1997; Mohan et al., 1995; Qin et al., 1998; Jones and 
Clemmons, 1995; Firth and Baxter, 2002; Rechler and Clemmons, 1998].Their affinity to bind 
IGFs is equally or even higher than that of the IGF1R [Duan and Xu, 2005]. Within the brain 
IGFBP-2 to -5 are the most abundant. The IGFBPs are expressed within the CNS in a 
specific temporal-spatial pattern, but their exact function needs further investigation. 
There are differencing proposals on how they might act: (1) transport proteins in the plasma, 
(2) prolongation of the half live of IGFs during circulation, (3) determination of the tissue- and 
cell-specific localization of IGFs and, (4) control the biological actions of IGFs via modulation 
of the interaction with their receptor [Jones and Clemmons, 1995; O'Kusky and Ye, 2012].  
Additionally to this some IGFBPs may act independent to the IGFs. IGFBP-1 is for instance 
able to activate integrin-mediated intracellular signaling in trophoblast and enhances 
oligodendrocytes migration [Gleeson et al., 2001, Chesik et al., 2010]. Furthermore IGFBPs 
reduce the beneficial effect of IGF-I as a neurotrophic and survival factor for postnatal 
neurons [Vaught et al., 1993]. IGF-I has an important potential for treatment of amyotrophic 
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lateral sclerosis (ALS). It has been shown that IGF-I in combination with glial cell line-derived 
neurotrophic factor was able to rescue completely rat motor neurons from chronic glutamate-
mediated toxicity and showed a additive neuroprotection [Bilak, Corse and Kuncl, 2001]. 
As the IGFBPs modulate the action of the IGFs, they are themselves regulates through 
IGFBP proteases [Mohan et al., 2002].  
 
1.1.4. Insulin receptor substrates 
 
Upon insulin or IGFs binding to the InR or the IGF1R a conformational change is triggered, 
leading to the autophosporylation of the β-subunits. Afterwards the IRS are recruited to the 
receptor, which leads to phosphorylation of the IRS proteins. There are at least 4 IRS 
proteins known, IRS-1 to IRS-4 [Sun et al., 1991; Lavan et al., 1997; Lavan, Lane, and 
Lienhard, 1997]. In 1985 the first IRS was found and called pp185 (as it is 185kDa in size). It 
was cloned in 1991 and later named IRS-1 [White, Maron, and Kahn, 1985; Sun et al., 1991]. 
Furthermore, IRS-2 (160kDa) was discovered 1995 and IRS-3 (60kDa) likewise IRS-4 
(160kDa) in 1997 [Sun et. al., 1995; Lavan et al., 1997; Lavan, Lane, and Lienhard, 1997].  
The IRS proteins are widely expressed in the CNS, IRS-1, -2, -4 and Gab-1 in an tempo-
spatial specific pattern [Fantin et al., 1999; Folli, 1994; Holgado-Madruga, 1996; Numan and 
Russell, 1999; Sciacchitano and Taylor, 1997; Ye, Li, Lund and D’Ercole, 2002] and only a 
small amount of IRS-3 proteins are dectected in the adult brain [Sciacchitano and Taylor, 
1997]. All of the IRS have a similar structure. They consists of a N-terminal pleckstrin 
homology (PH), a phosphotyrosine-binding (PTB) domain and C-terminus, which contains 
multiple tyrosine phosphorylation sides. Those phosphortyrosine motifs are binding sides for 
Src homology (SH) 2 domain containing proteins [Yenush and White, 1997; White, 1997]. 
The PTB domain is able to bind to the phosphorylated NPXP motif at the juxtamembrane 
domain of the receptor, after IGFs or Insulin has bound, linking the IRS proteins to the 
particular receptor [Cheatham and Kahn, 1995; White, 2002]. The PH domain couples to 
lipids and with a high affintiy to phosphoinosides [Fruman, Rameh and Cantley, 1999; Moll, 
Zemva and Schubert, 2011].  
There are 21 putative tyrosine phosphorylation sides within IRS-1 and in different tyrosine 
kinase specifity motives [Songyang, 1995; Sun et al., 1991]. Compared to IRS-1, 14 of this 
tyrosine phosphorylation sides are conserved, four sides contain alternate surrounding 
sequences, three are not found and four sides are exclusively present in IRS-2 (Fig. 4) [Sun 
et al., 1995; White, 1997]. In contrats to IRS-1, IRS-2 includes a domain that can bind to the 
phosphorylated kinase regulatory loop of the β-subunit of the InR. It is called KLRB domain 
[Sawka-Verhelle et al., 1997; Sawka-Verhelle et al., 1996] and its physiological function 
remains unclear [Moll, Zemva and Schubert, 2011].  
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Insulin binding induces tyrosine and serine phoyphorylation in IRS-1 [Gual, Le Marchand-
Brustel and Tanti., 2005]. This serine phosphorylation is a tool to regulate IRS-1 action, 
positives and negatives [Weigert et al., 2005; Weigert et al., 2008]. Responsible for the 
different effects are not ony the location of the Ser phosphorylation sites within the IRS-1 
protein but also the timing of the phosphorylation.The sides with positive effect are thought to 
be phosphorylated first, so that IRS-1 is protected from negative actions, due to 
phosphorylation at inhibitory residues [Weigert et al., 2005; Weigert et al., 2008; Gual, Le 
Marchand-Brustel and Tanti., 2005; Luo et al., 2007] and therefore preventing the 
association with tyrosine phosphatases [Luo et al., 2005]. Negative effects are caused by 
phosphorylation of serine sides near the PTB domain, this disrupts the association between 
IRS-1 and the particular receptor leading to degradation of IRS-1. If serine residues in the C-
terminus are phosphorylated, the interaction between IRS-1 and the phosphatidylinositide 
(PI)3-kinase might be disturbed [Gual, Le Marchand-Brustel and Tanti., 2005; Boura-Halfon 
and Zick, 2009]. Those serin sides are phosphorylated via serine kinases like mammalian 
traget of rapamycin (mTOR), PKCzeta and p70S6 (S6K) kinase [Boura-Halfon and Zick, 
2009, Herschkovitz et al., 2007; Gual et al., 2003; Moll, Zemva and Schubert, 2011]. Further 
Ser phosphorylation of IRS-1 might case insulin/ IGF-I resitance. Here c-Jun N-terminal 
kinase (JNK), mTor/S6K, inhibitory-κB kinase β (IKK β), SIK-2 and extracelluar signal 
regulated kinase (ERK) seem to be included [Moll, Zemva and Schubert, 2011; Boura-Halfon 
and Zick, 2009; Herschkovitz et al., 2007]. Furthermore it has been shown, that TNFα is able 
to induce serine phosphorylation of IRS-1 in cultured adipocytes and Fao cells, which inhibits 
insulin signaling [Hotamisligi,l 1996; Kanety, 1995; Shier, 1989]. 
The role of serine phosphorylation sides in IRS-2 are still under inverstigation. However it 
has been shown, that a disruption between IRS-2 and its receptor can be caused, via the 
phosphorylation of JNK at Thr 348 [Solinas et al., 2006].  
 
Even tough the IRS proteins contain the same functional domains, they regulate different 
processes due to their distinct cellular distribution and their individual abundance in specific 
cells. For both proteins it is known, that they play a role during insulin-stimulated glucose 
transport [Hara et al., 1994; Okada et al., 1994; Quon et al., 1994; White, 1997]. 
IRS-1 is able to mediate some neural actions, but it seems that it is not essential for neural 
IGF-I signaling [Pete, 1999; Schubert, 2003; Ye, Li, Lund and D’Ercole, 2002]. Deletion of 
IRS-1 expression does not inhibit IGF-I stimulated brain growth and myelin-specific 
expression [Ye, Li, Lund and D’Ercole, 2002]. Those mice showed a significant higher level 
of IRS-2 and -4, so that it is reasonable to assume that the different IRS proteins 
compensate for each other [O’Kusky ,2012]. 
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In contrast deleting IRS-2 globally (IRS-2 (-/-)) [Schubert, 2003] or specific within nestin-
expressing cells [Taguchi, 2007], decreased brain weight by 30-38 %. It seems that IRS-2 
plays a more significant role in mediating IGF-I/ insulin signaling in the CNS. IRS-2 (-/-) mice 
exhibit at E14-E16 less proliferating neural cells, but no changes in apoptosis [Schubert, 
2003]. Thus IRS-2 appears to be able to transduce proliferation signaling at this stage, on the 
other hand it is not crucial for pro-survival signaling. However IRS-2 is competent of 
mediating pro-survival signaling in certain cells. Which was shown via an incresed number of 
apoptotic photoreceptors (50%) in the retina of 2 weeks old IRS-2 (-/-) mice [O’Kusky, 2012; 
Yi et al., 2005]. Furthermore, a decreased amount of multiple myelin-specific proteins 
appeared during the first two weeks of postnatal life [Freude et al., 2008], which is 
compensated during ageing in IRS-2 (-/-) mice [Freude et al., 2008, O’Kusky, 2012]. 
 
 
Figure 4: IRS-1 and IRS-2 and their phosphorylation sites 
At the NH2-terminus is schematic shown the two or rather three conserved modules (IH1
PH, IH2PTB and SAIN), 
which are believed to interfere with receptors or other interaction partners. Putative tyrosine phosphorylation sides 
are pictured in the COOH-terminal region. In open boxes entirely unique sides and conserved (but not absolutely) 
motifs are displayed in black boxes. Visible is that IRS-2 is about 100 residues longer than IRS-1. [White, 1997] 
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1.1.5. Phosphatidylinositide(PI)3 kinase signaling 
 
There are three classes of PI3K (class I-III) and class I is further subdivided into Ia and Ib 
[Vanhaesebroeck et al., 2005]. These kinases are heterodimeric containing a 110kDa 
catalytic subunit (p110) and a regulatory subunit (p85). The catalytic subunit is non-
covalently connected to the regulatory [Moll, Zemva and Schubert, 2011]. Class Ia is the best 
characterized and multiple Ia isoforms for the regulatory subunit (p85α, p85β, p55α, p50α 
and p55γ) and the catalytic subunit (p110α, p110β and p110δ) are known [Wymann and 
Pirola, 1998; Acebes and Morales, 2012]. This Class of PI3K is involved in the IGF1 and 
insulin signaling pathway [Fruman, Meyers and Cantley, 1998]. After activation of the InR 
and IRS binding, the PI3K is recruited to the membrane via the p85 regulatory subunit. 
Furthermore other factors, such as growth factor receptor binding protein (GRB)-2 and the 
SH2 Phosphatase (SHP)2 are recruited to the IRS proteins. The catalytic subunit 
phosphorylates phosphatidylinositide-diphosphate (PI4,5P) to generate phosphatidylinositide-
triphosphate (PI3,4,5P) [Vanhaesebroeck et al., 2001; Wu et al., 2007]. The opposing 
phosphatase of this reaction in PTEN (the phosphatase and tensin homolog deleted on 
chromosome ten), which can induce a reverse [Maehama and Dixon, 1998]. After the 
generation of PI3,4,5P further downstream targets are activated, like phosphoinositide-
dependent protein kinase(PDK)-1/-2, protein kinase B (PKB, also known as AKT), and 
inhibition of glycogen synthase kinase-3 (GSK-3) is induced. PKB is found in two isoforms 
PDK-1 and PDK-2. PDK-1 can partly activate the serine/ threonine kinase AKT (57kDa) by 
phosphorylation at Thr308, but for full activation the phosphorylation of Ser473 is required 
[Alessi et al., 1996; Lawor and Alessi, 2001; Stokoe et al., 1997; Freude, 2010]. The three 
isoforms of AKT contain a conserved kinase domain, a PH-domain at the N-terminus next to 
a regulatory subunit at the C-terminus [Hresko, Murata and Mueckler, 2003]. Furthermore 
PI3,4,5P activates AKT, which leads to phosphorylation of tuberin 2 (TSC-2). A heterodimer of 
TSC-1 and TSC-2 with GTPase activity is formed, which then can inhibit the GTPase RHEB 
(RAS homolg enriched in brain) [Astrinidis and Henske, 2005; Hay and Sonnenberg, 2004]. 
PDK-1 and mTOR activate via phosphorylation S6K. mTor itself is negatively regulated 
through GSK-3 and human tuberin [Ruggero and Sonenberg, 2005; Manning and Cantley, 
2007; Acebes and Morales, 2012] . The regulation of protein synthesis via IGF-I starts due to 
the control of the intrinsic activity and/or binding properties of specific translation initiation 
(sIFs) and elongation factors (eEFs). Phosphorylation of 4E-BP (4E binding protein) via 
mTOR leads to the release of eIF4E (eukaryotic initiation factor 4E). eIF4E is now able to 
form an active complex. This complex formation boosts the start of translation and the 
activation of S6K [Nojima et al., 2003; Oshiro et al., 2004; Freude, 2010; Moll, Zemva and 
Schubert, 2011]. 
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Furthermore GSK-3β, a major tau kinase and BAD (Bcl-2 Bcl-X-associated death promoter), 
a proapoptotic factor are inactivated [Song, Ouyang and Bao, 2005] via the InR and IGF1R 
signaling cascade. BAD interacts with Bcl-2, a apoptosis suppressor, but more intensely with 
Bcl-XL via its BH3 homology domain [Yang et al., 1997; Zha et al., 1997]. This is regulated 
via the phosphorylation state of BAD by the InR/ IGF1R signaling cascade.  
Taken together the IGF1R signaling pathway is potent in inhibiting neural apoptosis 
[Schubert et al., 2003; Moll, Zemva and Schubert, 2011]. 
 
1.1.6. Glycogen synthase kinase-3 
 
GSK3 is a constitutive active kinase, which regulates cell metabolism by phosphorylation of 
glycogen synthase (GS) and other substrates. Inhibition of GS through GSK3 leads to a 
reduction of glycogen synthesis and inhibition of GSK3 to increased glycogen synthesis 
[Henriksen and Dokken, 2006; Lee and Kim, 2007]. Upon stimulation of the InR/ IGF1R 
signaling cascade phosphorylation of GSK3α/β at the regulatory of Ser21(α) or 9(β) leading 
to inhibition of the kinase [Gao, Hölscher, Liu and Li, 2012]. Alternatively GSK3 is activated 
via protein kinase C (PKC). It has been shown, that inhibition of PI3K and PKC results in 
over activation of GSK3 [Liu et al., 2008]. Additionally GSK3 is able to regulate protein 
synthesis via controlling inhibition factor 2B (IF2B) activity [Welsh and Proud, 1993; Van 
Wauwe and Haefner, 2003]. 
Moreover GSK3 is also involved in Wnt signaling. Thus GSK3 is a connection between the 
InR/ IGFR- and the Wnt-signaling pathway. The essence of Wnt is the phosphorylation/ 
degaradation of cytosolic β-catenin (Figure 5). Is Wnt absent, cytoplasmic β-catenin is 
permanent degraded by the axin complex. This axin complex consists of the scaffolding 
protein axin, the tumor suppressor adenomatous polyposis coli gene product (APC), casein 
kinase 1 (CK1), and GSK3. Axin uses different domains to interact with GSK3, CK1 and β-
catenin. It thereby coordinates sequential phosphorylation of β-catenin at Ser45 by CK1α, 
followed by phosphorylation of Thr41, Ser37 and Ser33 by GSK [Kimelman and Xu, 2006; 
He et al.,2004]. If β-catenin is phosphorylated at Ser33 and Ser 37, a binding site for E3 
ubiquitin ligase β-Trcp is created, which leads to ubiquitination and degradation by the 
proteasome [He et al 2004]. Due to β-catenin degradation, Wnt target genes are repressed 
by the DNA-bound T cell factor lymphoid enhancer factor (TCF/ LEF) family of proteins (Fig 5 
A: Wnt off state). 
Activation of the Wnt pathway occurs via Wnt ligand binding to a seven-pass transmembrane 
Frizzled (Fz) receptor and its co-receptor, low-density lipoprotein receptor related protein 6 
(LRP6) or its close relative LRP5. The Wnt-Fz-LRP6 complex is formed and recruitment of 
the scaffolding protein Dishevelled (Dvl) results in LRP6 phosphorylation and activation. In 
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additional the axin complex is guided to the receptors. This results in the inhibtion of axin-
mediated β-catenin phosphorylation and hence stabilization of β-catenin takes place, which 
can now reach the nucleus to form a complex with TCF/LEF and activates Wnt target gene 
expression (Fig 5 B: Wnt on state) [MacDonald, Tamai and He, 2009]. 
 
 
Figure 5: Wnt/β-catenin signaling 
A) Wnt-off state: Wnt is absent, therfore cytoplasmic β-catenin forms a complex with axin, APC, GSK3 and CK1 
and is phosphorylated by CK1 (blue) and subsequently by GSK3 (yellow). Phosphorylated β-catenin is recognized 
by the E3 ubiquitin ligase β-Trcp, which targets β- catenin for proteosomal degradation. Wnt target genes are 
repressed by TCF-TLE/Groucho and histone deacetylases (HDAC).  
B) Wnt- on state: Is Wnt ligand present, a receptor complex forms between Fz and LRP5/6. Dvl recruitment by Fz 
leads to LRP5/6 phosphorylation, and axin recruitment. This disrupts axin-mediated phosphorylation/degradation 
of β-catenin, allowing β-catenin to accumulate in the nucleus where it serves as a co-activator for TCF to activate 
Wnt responsive genes. [MacDonald, Tamai and He, 2009] 
 
1.1.7. Forkhead box O transcription factors 
 
The mammalian forkhead box O transcription factor (FoxO) family consists of four members, 
FoxO1, FoxO3a, FoxO4 and FoxO6 [Clark et al., 1993]. All of these contain a conserved 
forkhead domain (FKHR) and recognise a consensus Foxo-recognised element (FRE). The 
sequence of this element is (G/C)(T/A)AA(C/T)AA [Biggs et al., 1999; Furuyama et al., 2000; 
Gilley, Coffer and Ham, 2003] and present for intance in IGFBP-1 [Barthel, Schmoll, and 
Unterman, 2005; Cichy et al., 1998], Fas ligand (FasL) , p27KIP1 [Dijkers, Medema, Pals et 
al., 2000; Medema et al., 2000], Bim [Dijkers et al., 2000] and MnSOD [Kops et al., 2002]. 
FoxOs regulate genes that are involved in apoptosis, metabolism, growth, ageing and 
development [Partridge and Bruning, 2008]. 
FoxO1 and 3a are ubiquitously expressed, 6 is only found in the brain and 4 has yet not been 
detected in the brain [Furuyama et al., 2000; Jacobs et al. 2003]. FoxO1 is predominantly 
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expressed in the adult brain in the in the striatum, dentate gyrus and ventral hippocampus 
and FoxO3a in the cortex, cerebellum and hippocampus. FoxO6 has been detected in the 
amygdala, hippocampus and cingulite cortex [Hoekman et al., 2006]. 
The FoxOs are phosphorylated by AKT, which induces binding of 14-3-3 and therefore 
nucleus exclusion leading to the termination of the FoxO-mediated transcription. Depending 
on the stimulus there are other kinases beside to AKT which are able to phosphorylate 
FoxOs [Huang and Tindall 2007]. For instance FoxO1 can additionally be phosphorylated by 
dual-specificity tyrosine-phosphorylated and regulated kinase (DYRK). DYRK phosphorylates 
FoxO1 at Ser329. Whereupon FoxO1 activity is inhibited [Woods et al., 2001]. Additionally 
glucocorticoid-inducible kinases (SGKs) are able to phosphorylate FoxOs [Brunet et al., 
2001]. Furthermore activation of the C-Jun-N-Terminal kinase (JNK) upon oxidative stress 
leads to nuclear localization of FoxO3a (Lehtinen et al., 2006). 
After the exclusion from the nucleus FoxOs are targeted for proteasome-mediated 
degradation. FoxO1 is polyubiquitilated by e.g. Skp2, the substrate-binding component of the 
Skp1/culcin 1/F-box protein(SCFSkip) E3 ligase complex. In addition to phosphorylation, 
acetylation is another posttranslational modification of FoxOs. For example CBP and p300 
with their associated proteins like CBP- and p300 associated factor (PCAF) show intrinisic 
histone acetyl-transferase activity [Li et al., 2003]. Due to acetylation via CBP FoxO 
transcription factors are inhibited [Daitoku et al., 2004]. Deacetylation is achieved through the 
silent information regulator 1 (SIRT1), which is a nicotinamide adenine dinucleotide(NAD)-
dependent histone deacetylase. Upon stress stimuli SIRT1 forms a complex with acetylated 
FoxOs and [Brunet et al., 2004; Kitamura et al., 2005] to regulate FoxO mediated 
transcription via deacetylation.  
 
1.1.8. MAPK signaling 
 
The second main signaling pathway that InR and IGF1R activate is the mitogen activated 
protein kinase (MAPK) cascade. This pathway is one of the primordial signaling systems 
nature has used in different permutations to achieve a variety of tasks. This basic 
arrangement consists of a G-protein working upstream of a core module including three 
kinases: a MAPK kinase kinase (MAPKKK) that phosphorylates and activates a MAPK 
kinase (MAPKK) that then activates MAPK. This provides strong signal amplification and 
besides this allows additional control (Fig.6) [Kolch, 2000]. 
Is the receptor activated, the IRS proteins get phosphorylated and GRB-2 is feasible to bind 
[White, 2002]. GRB-2 binds to son of sevenless (SOS), a GDP/GTP exchange factor. SOS is 
towed to the membrane during this process by the growth-factor-receptor bound protein 2 
adapter protein that spots tyrosine phosphate docking sites [McCormick, 1993]. This leads to 
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the activation of the small G protein RAS and to the recruitment of CRAF (c-raf leukemia viral 
oncogene) and finally the extracellular signal-regulated kinases (ERK)-1/-2 are activated 
[Kolch , 2000]. Transcriptional activity is stimulated through activated ERK via direct 
phosphorylation of ELK-1 member of ETS oncogene family) and FOS (FBJ osteosarcoma 
oncogene). It is known that ERK-1 and -2 activity is important for long-term potentiation and 
memory consolidation in the CNS [Sweatt, 2001]. However if ERK-1 and -2 is overactive it 
might induce cell death in case of oxidative stress or growth factor deprivation [Zhuang and 
Schnellmann, 2006]. 
 
 
Figure 6: The Multi-protein signaling complexes 
Interactions between the proteins are indicated by lines. All possible interactions are shown. Kinases are pictured 
red; G-proteins green; phosphatases in pink, adapters in dark yellow, chaperones in light yellow, and transcription 
factors in blue with black letters. The minus symbol indicates that RKIP dissociates the interaction between Raf 
and MEK. [Kolch, 2000] 
 
1.2. Multiple sclerosis 
 
Multiple sclerosis (MS) is an inflammatory demyelinating disease that attacks the brain, 
spinal cord and optic nerves in the CNS, but does no affect the nerve roots and peripheral 
nerves. The pathology appears as follows: 1) primary demyelination with little damage to 
oligodendrocytes, 2) demyelination and extensive oligodendrocytes loss 3) primary 
oligodendrocyte loss with secondary demyelination; and 4) activation of macrophages 
causing non-selective tissue damage, where not only myelin and oligodendrocytes are 
involved but also astrocytes and axons. Axonal loss is an unstoppable result of MS and 
might be the pathological correlate of the irreversible neurological impairment of this disease 
[Ferguson, Matyszak, Esiri and Perry, 1997; Lovas et al., 2000; McGavern et al., 2000; Trapp 
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et al., 1998]. Interestingly oligodendrocytes progenitors are present in the lesion of MS, but 
are fail to remyelinate those regions [Scolding 1998; Wolswijk; 1995; Wolswijk; 2000]. 
Mostly the first clinical symptoms of MS appear between 15 and 50 years of age. However, 
there are MS cases known not older than 3 or older than seventy years of age [McFarlin and 
McFarland, Part 1 and 2, 1982]. Females are twice as often affected than males. This 
disease has usually a relapsing-remitting course where neurologic episodes are repeated 
and followed by partial or even complete recovery or with periods free of new symptoms. If a 
patient has relapsing-remitting MS they mostly develop secondary progressive MS, where 
there is progressive bettering. 10% of MS patients emerge as primary progressive form, 
which means progressive neurologic deterioration with superimposed reacceleration. MS 
patients are able to live up to 40 years after onset of the disease [Pender and Greer, 2007]. It 
is a disease which, is not necessarily life shortening, but it worsens quality of life through 
deficits of sensormotoric, autonomic and neurocognitive functions [Sospedra and Martin, 
2005].  
MS is thought to be a CD4+ Th1-mediated disease [McFarland and McFarlin, 1992; Hafler, 
2004]. This idea has raised from data of experimental allergic (autoimmune) 
encephalomyelitis (EAE) experiments. EAE models show similarities with MS to human, 
because the injections of myelin components into susceptible animals leads to CD4+- 
mediated autoimmune disease [McFarland and McFarlin, 1992; Zamvil and Steinman, 1990]. 
Are those CD4+ T cells transferred into a normal healthy animal, they induce EAE in the 
healthy animal [McFarland and McFarlin, 1992; Zamvil and Steinman, 1990; Pettinelli and 
McFarlin, 1981]. There are only two known options to transfer EAE, CD4+ T cells and CD8+ T 
cells, but not via antibodies [Huseby et al., 2001; Sun et al., 2001]. Indirectly this hypothesis 
is supported by the knowledge that certain HLA class II molecules are the strongest genetic 
risk factors for MS. However the breakdown of the blood-brain barrier (BBB) and virus-
induced demyelination might be a primary and important events in the pathological 
manifestation of MS [Wekerle, 1993; Fazakerly and Buchmeier 1993]. Alteration of the BBB 
allows circulating antibodies the entry into the CNS, especially demyelinating antibodies such 
as anti- myelin oligodendrocyte glycoprotein (MOG) antibodies [Genain et al., 1996; Genain 
et al., 1999; Linington et al., 1988; Brosman and Raine; 1996]. Activated T cell trigger the 
release of proinflammatory cytokines, such as TNFα and interferon-γ by inflammatory cells, 
macrophages and microglia [Brosman and Raine; 1996]. Other mechanisms beside this 
might be that oligodendrocytes engulf a high iron content and are therefore prone to 
oxidative stress by reactive oxygen species [Griot, Burget, Vandevelde and Peterhans, 
1989]. Neurotransmitter e.g. glutamate can also act negatively on oligodendrocytes and 
induce demyelination [Matute, 1998; Pitt, Werner and Raine, 2000; Steinman, 2000].  
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Furthermore a group of zinc-dependent enzymes, the matrix metalloproteinases (MMP) 
which degrade extracellular matrix components [Yong et al., 1998]. Additionally MBP 
[Chandler; 1995] is increased in active and chronic MS [Maeda and Sobel; 1996]. Especially 
MMP-7 and MMP-9 are elevated [Cossins et al., 1997]. It seems that there is more than one 
mechanism present in the same affected MS lesion [Ludwin; 1997]. 
Beside the autoimmune hypothesis environmental and genetic MS risk factors have been 
discussed as influencing factors. For example dietary intake and/ or UV metabolized Vitamin 
D3 is able to lower the incidence of MS [Ramagopalan et al., 2009]. However this is no 
explanation for the appearance of MS in regions, where the population is are able to receive 
Vitamin D through UV metabolism or diet [Yamasaki et al., 1996; Niino et al., 2002; Maghzi 
et al., 2010]. A genetic explanation or the pathogenesis fails, as genetically similar 
populations exposed to similar pathogens, e.g. environment, have drastically different 
incidence of the disease [Benois and Mathis, 2001]. Furthermore another hypothesis 
proposes, that MS is a disease provoked by dysfunction of lipidmetabolism [Corthal, 2011]. 
Taken together there are a lot of factors known to be involved, but a comprehensive 
understanding of the pathogenesis has not yet been reached.  
 
1.2.1. Myelin and its general composition 
 
More than 20 years ago as methods of myelin isolation became available the composition of 
myelin has been studied intensively. Myelin is the essential constituent of the white matter in 
the CNS [Notron and Poduslo, 1973; Norton and Poduslo, 1973]. Myelin itself consists of 
70% lipids and 30% proteins. Unique is the lipid-to-protein ratio in the myelin membrane, 
because it is exactly reverse as in other cellular membranes [Martenson, 1992; Morell et al., 
1994; Siegel, Albers, Brady and Price; 1994; Juurlink et al., 1997]. This multilayered 
membrane system enwraps axons with a distinct periodic structure. Oligodendrocytes 
produce and extent this membrane system in the CNS. Up to 50 axon segments (internodes) 
can be myelinated by one oligodendrocyte [Hildebrand, Remahl, Persson and Bjartmar, 
1993]. Those internodes are separated by short stretches of bare axolemma (nodes of 
Ranvier) (Fig.7). The myelin internode consists morphologically of compact myelin that built 
the majority of the internode, and noncompact myelin, which primarily frames the edges of 
the internode [Soldán and Priko, 2012]. Compact myelin are spiralled sheets around the 
axons, which consists of two plasma membranes that form a lamellar structure with in turn 
electron-dense (major dense line) and electron-light (intraperiod lines) layers. The major 
dense line, are the fused cytoplasmic sites of the membranes, whereas the outersides of the 
membrane are connected in the intraperiod lines. Cytoplasm is excluded in compact myelin, 
but extracellular spaces are found at the intraperiod lines. There are also radial components, 
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which are composed of lines of junctional complexes registered both longitudinally and 
transversely, across the length of the internode and thickness of the myelin sheath thickness. 
Noncompact myelin might facilitate the communication between the oligodendrocyte soma 
and the myelin lamellae possible. Therefore the membrane forms at the inner- (periaxonal), 
outermost (abaxonal) and lateral (paranodal) edges channel-like tubes [Nave, 2010; Soldán 
and Pirko I., 2012; Aggarwal, Yurlova and Simons, 2011] 
The correct formation and maintance of myelin is important for the functioning of the 
vertebrate nervous system. Because myelinated nerve fibers allow the rapid, focused signal 
transduction such as the voluntary and reflex stimulation of locomotory muscles and the 
perception of external stimuli [Tzakos et al., 2005]. 
 
 
 
Figure 7: The axon myelin unit  
Myelin sheat in cross section (inset: electron micrograph), with its characteristic periodic structure with alternating 
electron-dense (major dense line) and electron-light (intraperiod line) layers. At the lateral margins, noncompact 
cytoplasmic loops that abut the axolemma (inset: electron micrograph) and form junctional complexes. This 
defines distinct structural domains of axon-myelin contact: internode, juxtaparanode, paranode, and node. A 
cluster Na+ and K+ channels at the node and juxtaparanode. (Caspr, contactinassociated protein; Cntn, 
contactin; KCh, fast potassium channels; NaCh, voltage-gated sodium channels; NECL, nectin-like 
protein/synCAM; NF155/186, neurofascin 155kDa/186kDa; Nr-CAM, neuronal cell adhesion molecule) [Nave, 
2010]. 
 
1.2.1.1. Myelin lipids 
 
Myelin of mammalian species contains cholesterol, phospholipids and glycosphingolipids 
(GSLs). Those lipids are similar to the lipids found in every cellular membrane, but their ratio 
is unique for myelin. Cholesterol and GSLs built up to 31% of the total myelin lipids 
[Jackman, Ishii and Bamsal, 2009]. Myelin membranes are different in their biological 
properties, e.g. in fluidity and curving, due to the high cholesterol content [Huttner and 
Zimmerberg, 2001]. Structurally the GSLs found in myelin differ from those in the plasma 
membranes of other cell types. Headgroups are based on galactose instead of glucose, and 
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long fatty acids with high degree of oxidation are found [Norton and Poduslo, 1973; Jacque, 
Bourre, Moreno and Baumann; 1971]. Within the membrane GSLs are differentially located, 
Galactocerebroside (GalC) for instance is localized within compact and sulfatide in 
noncompact myelin [Maier, Hoekstra and Baron, 2008]. The biosynthesis is regulated via 
subcellular compartmentalization. On the cytoplasmasmic face of the endoplasmatic 
reticulum (ER) the synthesis of GSL is initiated by condensation of L-serine and palmitoyl-
CoA and besides this the formation of ceramide via reduction, acylation and desaturation 
reactions is achieved [Kolter, Proia and Sandhoff, 2002]. After the ceramide has been flipped 
to the luminal face of the ER, GalCs are formed through the addition of galactose residue. 
After this a certain amount of GalCs are converted to sulfatide on the luminal face of the 
Golgi. The GalC and sulfatides reach the outer leaflet of the plasma membrane via vesicular 
transport [Brown et al., 1993]. The cermaides are the precursors of galactolipids, 
gangliosides and sphingomyelin [Hannun and Obeid, 2002]. After ceramides are synthesized 
on the ER cytoplasmic face some of those are transfered to the Golgi cytoplasmic face and 
glucocerebrosides (GlcC) are formed via addition of a glucose residue [Ichikawa and 
Hirabayashi, 1998]. Galactose residues are added to GlcC, which are then via a flip 
transferred to the luminal face of the Golgi. During this transfer lactosylceramide (LacC) are 
formed [Lannert et al., 1998]. LacC are the precursor for most gangliosides, excluding 
sialosylgalactosylceramide (GM4) which are processed via sialyltransferases. Similar to the 
GalCs and sulfatides, gangliosides are transported by vesicular transport to the outer leaflet 
of the plasma membrane [Farrer and Benjamins, 1992]. 
 
1.2.1.2. Myelin proteins 
 
30% of the dry weight of myelin consists of proteins. The most known ones are specific 
components of myelin and oligodendrocytes. Major CNS myelin proteins are Myelin basic 
protein (MBP), Proteolipid protein (PLP) as well as its isoform DM20. They account for 22-
35% and 30-45% of the total proteins. Furthermore 2’,3’-Cyclic nucleotide-3’-phosphatase 
(CNP) makes up 4-15% of the remaining proteins [Norton and Podulso, 1973; Morell et al., 
1972; Deber and Reynolds, 1991; Jahn, Tenzer and Werner; 2009]. Between the remaining 
proteins is myelin-associated glycoprotein (MAG), which is a myelin glycoprotein at the inner 
surface of the myelin sheath opposing the axon surface and accounts for less than 1% of the 
total. Furthermore myelin-associated oligodendrocyte basic protein (MOBP), is exclusively 
expressed in oligodendrocytes and appears late in myelination. Its location is in the major 
dense line of compact myelin. Several splice variants exists and the 81 aa isoform is the 
most abundant in rodent and human myelin [Sospedra and Martin, 2005]. 
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1.2.1.2.1. Myelin basic protein 
 
MBP accounts for ~30% of the total myelin and is one of the major proteins of the CNS. It is 
found at the cytoplasmic surface of compact myelin membranes where it binds negatively 
charged lipids, maintaining the major dense line [Privat et al., 1979]. MBP is in fact a family 
of proteins, as there are a variety of isoforms with different molecular masses. The major 
isoforms have a molecular mass of 21.5, 18.5, 17 and 14kDa in mice and 21.5, 20.2, 18.5 
and 17.2kDa in human [Campagnoni and Macklin, 1988]. Those isoforms are alternative 
transcripts from the seven exon MBP gene [Roach et al., 1983]. Additionally, the MBP gene 
contains a larger transcriptional unit [Campagnoni et al., 1993; Grima, Zelenika and Pessac, 
1992; Pribyl et al., 1993]. This unit consists of three unique exons spanning region which is 
73 kb upstream of the MBP transcriptional start side in mice [Campagnoni et al., 1993]. It is 
called the Golli-MBP gene and is 195 kb in mice and 179 kb in humans [Campagnoni et al., 
1993; Pribyl et al., 1993]. The Golli and the MBP transcripts are regulated differently [Gow, 
Friedrich and Lazzarini, 1992]. A regulatory element for effective transcription in glial cells, 
e.g. a MBP promoter region of 256 bp, can drive direct oligodendrocyte specific expression 
[Goujet-Zalc et al., 1993]. 
The 17- and 21.5kDa isoform in mice appear earlier in development. While in contrast the 
20.2 and 21.5kDa isoforms are expressed mainly during myelinogenesis in human. But both 
are reexpressed in MS lesions and correlate with the remyelination in those lesions [Capello, 
Voskuhl, McFarland and Raine, 1997]. Posttranslational modifications of the MBP are as well 
known, e.g. NH2-terminal acetylation, citrullination, phosphorylation and methylation. 
Methylation might be important for the compaction of the membrane during maturation 
[Campagnoni and Macklin, 1988; Wood and Moscarello, 1989].  
Numerous pieces of evidence suggest that MBP might be a good candidate for an 
autoantigen in MS [Martin, McFaland and McFarlin, 1992]. In MS patients and controls MBP-
specific T-cells are described. Due to their activation state in MS patients, proinflammatory 
phenotype and higher antigen avidity suggest that they have been acitivated in vivo [Burns et 
al., 1983; Richert et al., 1983; Chou et al., 1989; Martin et al., 1990; Pette et al., 1990; Ota et 
al., 1990; Olsson et al., 1990]. On the other hand mice that express a TCR that is specific for 
an encephalitogenic peptide of MBP develop as well EAE [Goverman et al., 1993].  
 
1.2.1.2.2. Proteolipid proteins 
 
The gene which encodes for PLP is located on the X chromosome, is 15 kb in size and 
organized in six exons. PLP and its isoform DM20 are formed by alternative splicing and are 
therefore coded by the same gene [Morello, Dautigny, Pham-Dinh and Jolles, 1986; Nave, 
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Lai, Bloom and Milner, 1986]. PLP consist of four hydrophobic α-helices which span the 
whole tickness of the lipid bilayer, two extracytoplasmic and three cytoplasmic domains 
(including NH2- and COOH-termini). It is localized at the intraperiodic and major dense line of 
myelin [Popot, Pham-Dinh and Dautigny, 1991; Weimbs and Stoffel, 1992]. Its extracellular 
domains form electrostatic interactions with myelin lipids, thereby maintaining the intraperiod 
line [Griffiths et al., 1998]. 
In the absence of PLP/ DM20 oligodendrocytes are still able to myelinate axons and 
assemble compact myelin sheaths, but the ultrastructure of myelin exhibited condensation of 
the intraperiodic lines correlating with the reduced physical stability. This led to the 
conclusion, that PLP forms stabilizing membrane junctions after myelin compaction [Boison, 
Bussow, D’urso, Muller and Stoffel, 1995; Klugmann et al., 1997]. Furthermore the absence 
of PLP leads to widespread focal axonal swellings, which are followed by axonal degradation 
associated with impairment of motor performance [Griffiths et al., 1998; Baumann and Pham-
Dinh, 2001]. PLP and DM20 is mainly found in the brain, spinal cord and it has been 
detected in the peripheral lymphoid organs [Seamons, Perchellet and Goverman, 2003; 
Burno et al., 2002; Klein et al., 2000].  
 
1.2.1.2.3. 2’, 3’-Cyclic nucleotide-3’-phosphatase 
 
CNP represents 4% of total myelin proteins. This protein should hydrolyze 2’-3’-cyclic 
nucleotides into their 2’-derivates, but until now no 2’-3’-cyclic nucleotides has been found in 
the brain, the function of this enzyme is still obscure [Vogel and Thompson, 1988]. The gene 
is located on mouse chromosome 11 and 17q21 in humans [Bernier, Colman and 
D’eustachio, 1988]. The gene consists of four exons which span 17 kb. There are two 
isoforms of CNP, CNP1 (46kDa) and CNP2 (48kDa). The two isoforms are produced by 
alternative splicing starting from two transcript start sites. An upstream initiation codon is 
present in exon 0 and a splice site present in exon 1 [Kurihara et al., 1990]. Moreover two 
translational start sites can are known for the mRNA encoding the CNP2 isoform, which give 
rise to additional isoforms [O’Neill et al., 1997].  
CNP can be isolated within the myelin fraction, but it is not localized in compact myelin. In 
Oligodendrocytes CNP can be detected in the soma and in noncompact myelin at the inner 
and outer tongue processes and in the paranodal loops [Trapp et al., 1988]. It is 
posttranslational modified via acetylation and phosphorylation [Vogel and Thompson, 1988]. 
It is known that in vitro CNP copolymerizes with tubulin heterodimers and therefore 
promoting microtubule assembly [Lee et al., 2005]. Furthermore, it links tubulin and actin to 
membranes [Bifulco et al., 2002; De Angelis and Braun, 1996] by isoprenylation of its C-
terminal domain [De Angelis and Braun, 1994; Esposito et al., 2008]. CNP binds RNA and is 
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able to suppress protein translation [Gravel et al., 2009], which suggests that it is involved in 
trafficking of specific RNAs to distal parts of the oligodendrocyte at the glia-axonal junction 
[Edgar et al., 2009]. CNP and PLP are both not essential for myelination, but are required for 
axonal integrity [Lappe-Siefke et al., 2003]. CNP1-null mutant mice are more severely 
affected than PLP1-null mice, because their axons degrade just after a few weeks [Edgar et 
al., 2009]. 
 
1.2.2. Myelination and remyelination 
 
Myelination is subdivided in several subsequential steps: 1) migration of oligodendrocytes to 
the target axons, which the oligodendrocytes are able to recognize; 2) the adhesion process 
of the oligodendrocyte to the axon; 3) the wrapping of a predetermined number of myelin 
sheats around the axon and leaving the nodes of Ranvier unmyelinated.  
At first the preoligodendrocyte locate along the fiber tracts of the future white matter, still 
being able to divide. At this time mitoses are still present in the interfascicular longitudinal 
glial rows. Next the preoligodendrocyte become immature and are ready to start the 
myelination [Baumann and Pham-Dinh, 2001; Reynolds and Wilkin; 1991]. The onset of 
myelination might be determined by the degree of neural differentiation and not by the timing 
of an intrinsic oligodendrocyte differentiation program [Brinkmann et al., 2008]. The signal for 
the onset of myelination seems to be provided by the activity of neurons [Gyllensten and 
Malmfors, 1963; Omlin, 1997].  
To understand the signaling pathway of myelination and the main players of protein and lipid 
synthesis, models of remyelination were investigated. In most chronic lesions of MS are 
enough oligodendrocytes and premyelinating oligodendrocytes, but they fail to remyelinate 
[Chang et al., 2000, 2002; Lucchinetti et al., 1999; Ozawa et al.,1994; Scolding et al., 1998; 
Wolswijk, 2000, 2002]. This suggests that the microenviroment of MS lesions does not 
provide or inhibits the needed signals for remyelination. 
 
1.2.2.1. IGF1R signaling in myelination and remyelination 
 
It is known, that IGF-I is an important survival factor for oligodendrocytes and their 
precursors (OPCs) [Barres et al., 1992; Mason et al., 2000; McMorris et al., 1986; Ye and 
D’Ercole, 1999], which stimulate the synthesis of myelin [Roth et al., 1995]. Mice which over 
express IGF-I show an increased myelin content [Carson et al., 1993; Ye et al., 1995], in 
contrast, if IGF-I is deleted a strong reduction in myelination and in the numbers of OPCs 
occur [Beck et al., 1995]. However it has been shown that MS patients and healthy controls 
have the same IGF-I levels. Furthermore there is a consistent upregulation of IGF-I, IGF1R 
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and IGFBP-1 and -6 in oligodendrocytes at the edge of demyelinated MS lesions [Wilczak et 
al., 2008; Gveric et al., 1999]. In cell culture [Kühl et al., 2002] and in transgenic mice over 
expressing IGFBP-1 [Ye et al., 1995], IGFBP-1 has an inhibitory effect on IGF-I induced cell 
survival and myelination. The upregulation of IGFBP-1 and -6 might be one of the factors 
why remyelination fails in MS [Wilczak et al., 2008]. It has been suggested that progesterone 
might be a good candidate to therapy MS, as it is able to cross the BBB easily and reduces 
the expression of IGFBP-6 in oligodenrodrocyte cell cultures [Kühl et al., 2003]. Even not 
investigated in oligodendrocytes, progesterone is known to be a strong inhibitor of IGFBP-1 
expression in other cell lines [Davies et al., 2004]. Furthermore progesterone induces 
remyelination in animal models of toxin-induced CNS demyelination [Ibanez et al., 2004]. On 
the other hand IGFBP-1 appears to serve as a inhibitor of IGF-I induced differentiation and is 
able to induce OPC proliferation [Chesik et al., 2010]. 
Downstream in the IGF1R and InR signaling cascade it has been shown, that IRS-1 is not 
essential in IGF-I promoted oligodendrocyte development and myelination, and that IRS-2 or 
IRS-4 might be capable of compensating of the loss of IRS-1 in IRS-1 homozygous 
transgenic knockout mice (IRS-1 -/-) as they were up regulated [Ye et al., 2002]. For IRS-2 
homozygous knockout mice (IRS-2 -/-) it has been described that IRS-1 is up regulated and 
increased IGF1R signaling was observed at postnatal day (P)10-14. It seems that IRS-1 is 
able to compensate the loss of IRS-2, at least partially. But those mice presented less myelin 
proteins (MBP, PLP and MOBP) at P10, but unchanged qualitatively myelination. Therefore it 
was reasoned that IRS-2 is critical for appropriate initiation of myelination, but not for myelin 
maturation. Mice lacking the InR in the brain displayed unchanged myelination, suggesting 
that the myelination initiation signal is mainly transduced via the IGF1R [Freude et al., 2008]. 
 
1.2.2.2. Wnt signaling in myelination and remyelination 
 
As a bypass Wnt signaling seems to be involved in myelination. IRS-2 (-/-) mice showed 
between P5 and week 5 a higher amount of phosphorylated GSK3β (Ser9; p-GSK3β) 
[Freude et al., 2008]. Additionally other factors of the Wnt signaling cascade are known to be 
up regulated in EAE mice [Azim and Butt, 2011]. GSK3β inhibition is a major effect in the 
IGF1R cascade [Frederick et al., 2007], but is also controlled via the Wnt signaling pathway 
[Fancy et al., 2009; Feigenson et al., 2009]. In the dorsal horn of the spinal cord of EAE mice 
increased expression of Wnt3a, β-catenin, Wnt5a and its receptor (co-receptor) Ror2 
expression have been observed [Yuan et al., 2011]. Furthermore, it has been shown that 
inhibiting GSK3β results in an increase of OPCs and oligodendrocytes, promoting 
myelination. Inhibition of GSK3β stimulates OPC proliferation and acts prosurvival and 
antiapoptotic. Ser9 phosphorylation of GSK3β via the canonical Wnt signaling pathway in 
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oligodendrocytes regulates nuclear translocation of β-catenin. Wnt3a inhibition reduces 
oligodendrocyte differentiation, at least in the optic nerve. GSK3β inhibition might be able to 
overcome the negative effects of Wnt3a by stimulating cAMP response element binding 
(CREB) [Grimes and Jope, 2001], which activates Bcl2 gene expression to prevent cell death 
in oligodendrocytes [Saini et al., 2004]. Furthermore, GSK3β inhibition decreases Notch1 
signaling, which positively regulates oligodendrocyte differentiation but negatively 
myelination. These effects are similar during development as well as in the chemically 
induced de- and remyelination. Therefore GSK3β is a negative regulator of oligodendrocyte 
differentiation that contributes to inefficient regeneration of oligodendrocytes and myelin 
repair in demyelination [Azim and Butt, 2011].  
 
1.2.2.3. Fyn kinase in myelination and remyelination 
 
The Src family tyrosine kinase Fyn signaling is known to play a role in promoting 
oligodendrocyte differentiation, maturation and myelination [Wang et al., 2009]. Fyn is 
regulated via dephosphorylation of the C-terminal tail residue by protein tyrosine 
phosphatases (PTPs) [Umemori et al., 1999]. Therefore an essential player and central 
coordinator, as mice with Fyn deficiency exhibit hypomyelination [Umemori et al., 1994; 
Sperber et al., 2001]. There is a crosstalk to the IGF1R signaling cascade as Fyn is activated 
via IGF-I. However other factors activating Fyn are serum withdrawal, β1 integrin stimulation, 
netrin-1 interaction with the receptor Dcc and antibody-mediated crosslinking of MAG or 
FcRγ [Umemori et al., 1994,Osterhout et al., 1999; Nakahara et al., 2003; Colognato et al., 
2004; Liang et al., 2004; Rajasekharan et al., 2009; Sperber and McMorris, 2001]. Fyn 
signals to a variety of molecules that are important for oligodondrocyte morphology, 
regulating cytoskeleton rearrangement and process extensions involving focal adhesion 
kinase (FAK), Rho GTPases Rho, Rac1, Cdc42, Rho regulators p190 and p250 RhoGAP as 
well as tau protein [Liang et al., 2004, Hoshina et al., 2007; Wolf et al., 2001; Taniguchi et al., 
2003; Klein et al., 2002; Miyamoto et al., 2007].  
 
1.3. Mouse models 
 
The current study investigates the role of IRS-2 over expression in oligodendrocytes and 
their precursors. For IRS-2 it has bene shown [Freude et al., 2008], that IRS-2 deficiency 
leads to delayed myelin development, whereas IRS-1 seems to be of minor importance. The 
influence of increased IRS2 signaling on myelination in vivo is unknown. In order to achieve 
oligodendrocyte specifity the Cre/loxP system under the oligodendrocyte specific CNP 
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promoter was used [Edgar et al., 2004; Griffiths et al., 1998; Kassmann et al., 2007; Yin et 
al., 1998].  
 
1.3.1. IRS-2 over-expressing mouse 
 
The transgenic (tg) IRS-2 construct has been cloned into the rosa26locus (Fig.8). Since the 
rosa26locus is expressed ubiquitously, a "stop cassette" flanked by loxP sites has been 
cloned in front of the IRS-2 sequence. The resulting tg lRS-2 (IR) mice were viable. To 
induce site specific DNA recombination the Cre/loxP system was used. This system was first 
described in the bacteriophage P1. Necessary for this system is the 34 bp DNA sequence 
with two 13 bp inverted repeats and the asymmetric 8 bp space region called locus of X-over 
in P1 (loxP). This sequence targets the site of recombination. In addition the Cre 
recombinase, a 343 aa monomeric protein, is required for this system. For the in vivo study 
mouse lines carrying the loxP site flanked stop cassette followed by the IRS-2 gene in the 
rosa26locus were used. After deletion of the "stop cassette" using CNP-Cre mice, the IRS-2 
mice express transgenic eGFP and overexpress IRS-2. 
 
Figure 8: Cre/ loxP targeting strategy for the overexpression of IRS-2 in oligodendrocytes 
The upper panel presents the rosa26 targeting vector included IRS-2 and eGFP, which contains the splice 
acceptor (SA), the pCMV promoter region (CAG), the loxP sites (tringles) flanked neomycin resistance gene 
(NeoR) and westphale stop cassette (WSS), the IRS-2 gene which is followed by the FRT site flanked internal 
ribosomal entry site (IRES) and enhanced green fluorescent protein (eGFP). After homologous recombination this 
region is inserted into the Rosa26 locus of the mouse model (lower panel). 
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1.3.2. CNP promoter driven expression of the Cre recombinase 
 
The enzyme 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNP) is a widely used marker 
protein of myelin-forming glial cells [Chandross et al., 1999; Vogel and Thompson, 1988; 
Sprinkle,1989]. During the development of the brain, CNP is detectable in cells of 
oligodendrocyte lineage [Yu et al., 1994] and is maintained in mature oligodendrocytes 
throughout life. CNP is also expressed, at much lower levels, outside the nervous system in 
subsets of immune cells [Sprinkle et al., 1985], photoreceptor cells [Giulian and Moore, 1980] 
and the testes [Scherer et al., 1994].  
The CNP Cre mice were generated via homologous recombination in R1-ES cells, where a 
genomic fragment that included most of exons 1-3 of the CNP gene was replaced by the cre 
recombinase gene (Fig.9). The correct clone after puromycin selction was injected into a 
blastocyst and yielded chimeric mice. Those heterozygous (F1) offsprings were intercrossed 
to obtain homozygous (F2) mutants. Both heterozygous and homozygous mutant mice were 
viable and showed no abnormal behaviours during the first month of age [Lappe-Siefke et al., 
2003]. 
 
Figure 9: Strategy to include cre recombinase 
At the top the structure of CNP1 is shown, with its 4 exons (0-3), the targeted construct is in the middle and the 
target locus at the bottom. After homologour recombination, the CNP1 open frame is replaced by cre and a PGK-
puromycin selection cassette (PGKpuro). 
 
1.3.3. CNP-Cre mice, a model for multiple sclerosis 
 
It is known, that homozygous CNP deficient ( CC -/-) mice show normal myelin assembly, 
whereas the ultrastructure and physical stability are not visibly changed. However, 
throughout the white matter axons developed abnormal swellings and were progressively lost 
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leading to premature death mostly before one year of age. But neuronal cell death is not a 
feature in those mutant mice. Nissl staining of 3,5 month old CC -/- mice revealed that the 
density of oligodendroglial nuclei in the corpus callosum was unchanged. Additionally, it can 
not be excluded that axon functions are changed in the motor system of those mice when 
they reach an older age. Moreover CC -/- showed overall reduction of brain mass after seven 
month of age. However CC -/- mice showed decreased MBP in whole brain lysate, whereas 
this could not be seen in purified myelin. Whereas PLP expression showed no 
developmental delay in 11, 15 and 21 days aged mice. Hence no significant signs of 
dysmyelination was found [Lappe-Siefke et al., 2003; Nave et al., 2003]. 
The axonal changes are similar to those in PLP-deficient mice [Griffiths et al., 1998]. 
Therefore a connection between changed myelin structure and axonal loss is not unlikely 
[Boison et al., 1995; Rosenbluth, Stoffel and Schiff, 1996; Klugmann et al., 1997; Boison and 
Stoffel, 1994]. In MS and related animal models, acute white matter lesions are directly 
linked to axonal loss [Trapp et al., 1998; Wujek et al., 2002]. Therefore it is reasonable that 
loss of oligodendrocytes within a MS lesion might contribute to axonal demyelination and to 
the persistent clinical disabilities of MS patients [Lappe-Siefke et al., 2003]. 
 
1.4. Aims of the present thesis  
 
The influence of increased IRS-2 signaling on myelination in vivo is still unknown. Thus the 
following thesis aims to investigate the role of IRS-2 over expression in oligodendrocytes in 
vivo and vitro. In particular: 1) Does IRS-2 over expression change myelin development; 2) 
Can IRS-2 over expression alter myelin composition; 3) Influences IRS-2 over expression in 
oligodendrocytes motor coordination in vivo. 
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2. Material and Methodes 
 
2.1. Chemicals 
Acetic acid    Merck, Darmstadt, Germany 
Acrylamide / Bis-acrylamide 30%  Rotiphorese® Gel 30 (37.5/1) 
Carl Roth GmbH + Co. KG, Karlsruhe, German 
Agarose     Invitrogen Corporation, Carlsbad CA, USA 
Ammonium‐persulfate (APS)  AppliChem GmbH, Darmstadt, Germany 
Avertin     Sigma‐Aldrich Chemie GmbH, Steinheim, Germany 
β‐mercaptoethanol    Sigma‐Aldrich Chemie GmbH, Steinheim, Germany 
Bradford reagent    Bio‐Rad Laboratories GmbH; Germany 
Bromophenol blue    AppliChem GmbH, Darmstadt, Germany 
96 % Bovine serum albumin (BSA) Sigma‐Aldrich Chemie GmbH, Steinheim, Germany 
Cresyl violet acetate   Sigma‐Aldrich Chemie GmbH, Steinheim, Germany 
DMSO Dimethyl sulfoxide  Sigma‐Aldrich Chemie GmbH, Steinheim, Germany 
DTT      Dithiothreitol  
AppliChem GmbH, Darmstadt, Germany 
EDTA     Ethylenediaminetetraacetic acid  
AppliChem GmbH, Darmstadt, Germany 
Ethanol     AppliChem GmbH, Darmstadt, Germany 
Ethidium bromide    Sigma‐Aldrich Chemie GmbH, Steinheim, Germany 
Geniticin (G418)   Sigma‐Aldrich Chemie GmbH, Steinheim, Germany 
Glycerol     Glycerin, AppliChem GmbH, Darmstadt, Germany 
Glycine     AppliChem GmbH, Darmstadt, Germany 
HEPES     Sigma‐Aldrich Chemie GmbH, Steinheim, Germany 
Hydrogen peroxide   Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Isopropanol     AppliChem GmbH, Darmstadt, Germany 
Kanamycin    AppliChem GmbH, Darmstadt, Germany 
LB-Agar    Sigma‐Aldrich Chemie GmbH, Steinheim, Germany 
LB-Medium    AppliChem GmbH, Darmstadt, Germany 
LY294002    Promega GmbH, Mannheim, Germany 
Methanol 99%    Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Magnesium chloride    Merck, Darmstadt, Germany 
NP‐40      Polyglycol ether (Nonidet® P40 Substitute) FLUKA 
Chemika/Biochemika Chemie AG, Buchs, Switzerlan 
PAP Pen    Abcam plc, UK 
PD98059    Sigma ‐Aldrich Chemie GmbH, Steinheim, Germany 
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PIPES     AppliChem GmbH, Darmstadt, Germany 
PMSF      Phenylmethylsulphonylfluoride  
Sigma‐Aldrich Chemie GmbH, Steinheim, Germany 
Paraformaldehyde (PFA)  AppliChem GmbH, Darmstadt, Germany 
Potassium chloride   Merck, Darmstadt, Germany 
Propidiumiodid   Sigma‐Aldrich Chemie GmbH, Steinheim, Germany 
Sucrose    AppliChem GmbH, Darmstadt, Germany 
SDS      Sodium dodecyl sulfate 
AppliChem GmbH, Darmstadt, Germany 
Sodium fluoride   Merck, Darmstadt, Germany 
Sodium bicarbonate    Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Sodium chloride    Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Sodium orthovanadate   Sigma‐Aldrich Chemie GmbH, Steinheim, Germany 
Solvent Blue 38   Sigma‐Aldrich Chemie GmbH, Steinheim, Germany 
TAE     AppliChem GmbH, Darmstadt, Germany 
TEMED     N,N,N',N'‐Tetramethylethylenediamine 
Sigma‐Aldrich Chemie GmbH, Steinheim, Germany 
Tris      AppliChem GmbH, Darmstadt, Germany 
TritonX-100     AppliChem GmbH, Darmstadt, Germany 
Trizol     Invitrogen Corporation, Carlsbad CA, USA 
Trypsin     Roche, Mannheim, Germany 
TWEEN 20®     Polyoxyethylene (20) sorbitan monolaurate,  
Caesar and Lorentz GmbH, Bonn, Germany 
Xylol      AppliChem GmbH, Darmstadt, Germany 
 
2.2. Enzymes 
Proteinase K    Fermentas GmbH, St. Leon-Rot, Germany 
T4 DNA Ligase   Fermentas GmbH, St. Leon-Rot, Germany 
XhoI     Fermentas GmbH, St. Leon-Rot, Germany 
BamHI     Fermentas GmbH, St. Leon-Rot, Germany 
SspI     Fermentas GmbH, St. Leon-Rot, Germany 
GoTaq® Hot Start Polymerase Promega Corporation, Madison, USA 
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2.3. Vectors, Primer and supplies 
Desoxy-Ribonucleotid-Triphosphate  
dNTPs     Fermentas GmbH, St. Leon-Rot, Germany 
pCMV-Tag 2C   Agilent Technologies, Santa Clara CA, USA 
pCMV-Tag 2B    Agilent Technologies, Santa Clara CA, USA 
 
2.4. Buffer and solution 
Solvent blue solution   0.13g Solvent blue 
     10ml 10% HCL 
     190ml 96% EtOH 
 
Cresyl violet solution   0.1g Cresyl violet 
     100ml distilled water 
     20 drops 10% HCl 
 
5% BSA solution   5g BSA  
     100ml PBS 
 
0,8% BSA solution   0.8g BSA 
     100ml PBS 
 
0,5% Triton-X solution  1ml Triton-X (10%) 
     19ml PBS 
 
SDS‐PAGE running buffer   194mM Glycine 
25mM Tris 
0.1% SDS 
 
4 x SDS sample buffer   250mM Tris‐HCl (pH 6.8) 
200mM DTT 
40% Glycerol 
8% SDS 
0.01% Bromophenol blue 
 
Stripping solution    62.5mM Tris‐HCL pH 6.8 
100mM β‐mercaptoethanol 
2%SDS 
 
TBS buffer (pH 7.6)    137mM NaCl 
20mM Tris 
 
TBS‐T buffer (pH 7.6)   137mM NaCl 
20mM Tris 
0.1% Tween 20® 
 
Western Blot antibody solution  137mM NaCl 
20mM Tris 
5% Western Blocking Reagent (Roche) 
 
Western Blot blocking solution  137mM NaCl 
20mM Tris 
10% Western Blocking Reagent (Roche) 
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Western Blot transfer buffer   194mM Glycin 
25mM Tris  
20% Methanol (99%) 
0.05% SDS 
 
DNA loading dye   50% Glycerin 
     5XTAE 
 
CaCl2 buffer    60mM CaCl2 
     15% Glycerin 
     10mM PIPES pH 7 
 
Tail biopsies lysis buffer  100 mM Tris HCl (pH 8.5),  
5 mMEDTA,  
0.2% (w/v) SDS,  
0.2M NaCl,  
500 mg/ml proteinase K) 
 
Cell lysis buffer    50 mM NaCl 
50 mM Tris‐HCl (pH 7.4) 
5 mM EDTA 
1 % Nonidet® P40 Substitute 
 
Organ lysis buffer    50 mM HEPES (pH 7.4) 
50 mM NaCl 
1 % Triton X-100 
10 mM EDTA 
0.1 M NaF 
17 µg/ml Aprotinine 
2 mM Benzanidine 
0.1 % SDS 
1 mM Phenylmethylsulfonyl fluoride (PMSF) 
10 mM Na3VO4 
Nuclear cell lysis buffer  420mM KCl 
     20mMHEPES 
     1mM EDTA 
     0,1mM Na3VO4 
     20% Glycerin 
 
Cytolsolic cell lysis buffer  10mM KCl 
     20mM HEPES 
     1mM EDTA 
     0,1mM Na3VO4 
     10% Glycerin 
     0,2% NP 40 
 
10x Cathode buffer   1M Tris 
     1M Tricine 
     1% SDS 
     pH 8.25 
 
10x Anode buffer   2.1M Tris 
     pH8.9 
ECL, Amersham ECLTM Western  
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Blotting Detection Reagents   GE Healthcare UK Ltd; England 
 
Fetal bovine serum (FBS)  Invitrogen GmbH; Germany 
 
Phosphate buffered saline 10 fold  
(pH 7.2)     Invitrogen GmbH; Germany 
 
PageRulerTM Prestained Protein  
Ladder     Fermentas GmbH, St. Leon-Rot, Germany 
 
Trypsin, 0.25% (1x) with EDTA Roche, Mannheim, Germany 
 
Western Blocking Reagent    Roche Diagnostics GmbH; Germany 
 
DMEM High Glucose with  
GlutamaxTM, 4500mg/L Glucose, 
Soduim Pyruvate   PAA Laboratories GmbH, Cölbe; Germany  
Pen/ Strep 
 
2.5. Cells and bacteria 
OmniMax    Invitrogen Corporation, Carlsbad CA, USA 
OLN-93 Dr. C. Richter-Landsberg (Department of Biology, 
Molecular Neurobiology, University of Oldenburg, 
Oldenburg, Germany 
 
2.6. Kits  
Qiaprep Spin Maxiprep Kit  Qiagen GmbH, Hilden, Germany 
QiAquick Gel Extraction Kit  Qiagen GmbH, Hilden, Germany 
Qiaprep Spin Miniprep Kit  Qiagen GmbH, Hilden, Germany 
BrdU assay    Millipore, Billerica, MA, USA 
METAFECTNE PRO   Biontex Laboratories GmbH, Germany 
 
2.7. Primary Antibodies 
 
2.7.1 Western Blot 
-Actin Antibody; Monoclonal mouse antibody detects an epitope conserved in human actin; 
MP Biomedicals, USA; Item # 69100; Western Blotting Dilution 1:5000 
 
-AKT Antibody; Polyclonal rabbit antibody detects endogenous levels of total AKT1, AKT2 
and AKT3 proteins; Cell Signaling Technology, Inc., USA; Item # 9272; Western Blotting 
Dilution 1:1000. 
 
-β-catenin Antibody; Monoclonal mouse antibody raised against amino acids 680-781 
mapping at the C-terminus of β-catenin of human origin; Santa Cruz Biotechnologie, Inc., 
USA, Item sc-133239tern Blotting Dilution 1:500 
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-Caspase-3 Antibody; Polyclonal rabbit antibody detects endogenous levels of full length 
caspase-3 (35kDa) and the large fragment of caspase-3 resulting from cleavage (17kDa); ; 
Cell Signaling Technology, Inc., USA; Item # 9662; Western Blotting Dilution 1:1000 
 
-CNPase Antibody; Polyclonal rabbit antibody detects human CNPase, Cell Signaling 
Technology, Inc., USA; Item # 2986; Western; Blotting Dilution 1:500 
 
-Erk Antibody; Polyclonal rabbit antibody detects endogenous levels of total p44/42 MAP 
kinase (Erk1/Erk2) protein; Cell Signaling Technology, Inc., USA; Item # 9102; Western 
Blotting Dilution 1:1000 
 
-Fyn Antibody; Polyclonal rabbit antibody detects endogenous levels of total Fyn proteins. 
This antibody does not cross-react with other Src and Hck family members; Cell Signaling 
Technology, Inc., USA; Item # 4023; Western; Blotting Dilution 1:500 
 
-GFP (D5.1) Antibidy; Monclonal rabbit antibody detects exogenous GFP; Cell Signaling 
Technology, Inc., USA; Item # 2959; Western Blotting Dilution 1:1000 
 
-GSK‐3β Antibody; Monoclonal rabbit antibody detects endogenous levels of total GSK‐3β 
protein; Cell Signaling Technology, Inc., USA; Item # 9315; Western Blotting Dilution 1:1000 
 
-IGF‐1 Receptor β Antibody; Polyclonal rabbit antibody detects endogenous levels of IGF‐IR 
β. Does not cross‐react with insulin receptor; Cell Signaling Technology, Inc., USA; Item # 
3027; Western Blotting Dilution 1:1000 
 
-IGFBP3 Antibody; Polyclonal goat antibody raised against a peptide mapping the C-
terminus of mouse origin; Santa Cruz Biotechnology, Inc., USA, Item: sc-6004, Western 
Blotting Dilution 1:250 
 
-InRβ Antibody; Polyclonal rabbit antibody detects a peptide mapping at the C-terminus of 
insulin Rβ (C19) of human origin; Santa Cruz Biotechnology, Inc., USA; Item # sc‐711; 
Western Blotting Dilution 1:1000 
 
-IRS‐1 Antibody; Monoclonal rabbit antibody detects C‐terminal 14 amino acid peptide 
([C]YASINFQKQPEDRQ) of rat liver IRS‐1. Rat, mouse and human crossreactivity; Upstate 
Cell Signaling Solutions, USA; Catalog # 06‐248; Western Blotting Dilution 1:1000 
 
-IRS‐2 Antibody; Polyclonal rabbit antibody detects endogenous levels of total IRS‐2 protein; 
Cell Signaling Technology, Inc., USA; Item # 4502; Western Blotting Dilution 1:1000 
 
-MBP Antibody; Polyclonal rabbit antibody detects endogenous levels of MBP; Abcam plc, 
UK, Item: ab40390; Western Blotting Dilution: 1:500 
 
-MMP9 Antibody; Polyclonal rabbit antibody detects full length (proenzyme, 92kDa) human 
and mouse MMP-9; Cell Signaling Technology, Inc., USA; Item # 2270; Western Blotting 
Dilution 1:1000 
 
-p27 (C-19) Antibody; Polyclonal rabbit antibody detects the C-terminus of p27; Santa Cruz 
Biotechnology, Inc., USA; Item #sc-528; Western Blotting Dilution 1:1000 
 
-Phospho‐AKT Antibody; Polyclonal rabbit antibody detects endogenous levels of AKT1 only 
when phosphorylated at Ser473. Also recognizes AKT2 and AKT3 when phosphorylated at 
the corresponding residues; Cell Signaling Technology, Inc., USA; Item # 9271; Western 
Blotting Dilution 1:1000 
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-Phospho-β-Catenin Antibody; Polyclonal rabbit antibody detects endogenous levels of 
human β-catenin when phosphorylated at Ser33, Ser 37 and Thr41; Cell Signaling 
Technology, Inc., USA; Item # 9561; Western Blotting Dilution 1:1000  
 
-Phospho‐p44/42 MAP Kinase (Thr202/Tyr204) Antibody; Polyclonal rabbit antibody raised 
against endogenous levels of p44 and p42 MAP Kinase (Erk1 and Erk2) when 
phosphorylated either individually or dually at Thr202 and Tyr204 of Erk1 (Thr185 and 
Tyr187 of Erk2); Cell Signaling Technology, Inc., USA; Item # 9101; Western Blotting Dilution 
1:1000 
 
-Phospho‐GSK‐3β (Ser9) Antibody; Polyclonal rabbit antibody detects endogenous levels of 
GSK‐3β only when phosphorylated at serine 9; Cell Signaling Technology, Inc., USA; Item # 
9336; Western Blotting Dilution 1:1000 
 
-Phospho‐GSK‐3α/β (Ser21)/(Ser9) Antibody; Polyclonal rabbit antibody detects endogenous 
levels of GSK‐3α/β only when phosphorylated at serine 21 or 9; Cell Signaling Technology, 
Inc., USA; Item # 9327; Western Blotting Dilution 1:1000 
 
-Phospho-p70 S6 Kinase (Thr389) Antibody, Polyclonal rabbit antibody detects endogenous 
levels of p-p70 S6 kinase only when phosphorylated at threonine 389, Cell Signaling 
Technology, Inc., USA; Item # 9205; Western Blotting Dilution 1:1000 
 
-p70 S6 Kinase Antibody, Polyclonal rabbit antibody detects endogenous levels of p70 S6 
kinase, Cell Signaling Technology, Inc., USA; Item # 9202; Western Blotting Dilution 1:1000 
 
-Phospho-PTEN (Ser380/Thr382/383) Antibody, Polyclonal rabbit antibody detects 
endogenous levels of phosphor-PTEN when phosphorylated at serine 380, threonine 382 
and threonine 383, Cell Signaling Technology, Inc., USA; Item #9549; Western Blotting 
Dilution 1:1000 
 
-PLP Antibody; Polyclonal rabbit antibody detects endogenous levels of PLP; Abcam plc, UK, 
Item: ab28486; Western Blotting Dilution: 1:500 
 
- PTEN Antibody, Monoclonal mouse antibody detects endogenous levels of PTEN; Thermo 
Fisher Scientific, Kalamazoo, USA; Item: MS-1601, Western Blotting Dilution 1:1000 
 
-TNFα Antibody; Monoclonal mouse antibody raised against full length recombinant TNFα of 
rat origin; Santa Cruz Biotechnology, Inc., USA, Item: sc-80383, Western Blotting Dilution 
1:250 
 
- Wnt5a Antibody; Polyclonal goat antibody detects endogenous levels of Wnt5a; Santa Cruz 
Biotechnology, Inc., USA, Item: sc-23698, Western Blotting Dilution 1:250 
 
2.6.2. Immunohistochemistry  
 
- GFAP Antibody, Polyclonal guinea pig detects endogenous levels of GFAP, Synaptic 
Systems, germany; Item: Cat.No.173004, IHC Dilution 1:200 
 
- GFP Antibody; Polyclonal rabbit antibody detects edogenous levels of GFP and is directed 
against the entire GFP molecule; Abcam plc, UK, Item: ab290; IHC Dilution: 1:50 
 
- MAC-2 Antibody; Monoclonal mouse antibody detects endogenous levels of MAC-2 (Clone 
M3/38); Biozol Diagnostica Vertrieb GmbH, Germany; Item # CL8942AP; IHC Dilution 1:100 
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-MBP Antibody; Polyclonal rabbit antibody detects endogenous levels of MBP; Abcam plc, 
UK, Item: ab40390; IHC Dilution: 1:500 
 
-PDGFR-α, Polyclonal rabbit antibody detects epitope mapping at the C-terminus of PDGFR-
α of human origin, santa cruz biotechnology, inc., USA, Item sc-338, IHC Dilution 1:50 
 
-PLP Antibody; Polyclonal rabbit antibody detects endogenous levels of PLP; Abcam plc, UK, 
Item: ab28486; IHC Dilution: 1:100 
 
- T-cell CD-3 Antibody; The 17A2 antibody recognizes ε/γ (but not ε/δ) of the CD3 complex. 
The antibody was purified by affinity chromatography, and conjugated with Alexa Fluor® 488 
under optimal conditions.; Biolegend Inc., San Diego, USA; Item # 100210; IHC Dilution 1:50 
 
2.7. Secondary Antibodies 
 
2.7.1. Western Blot 
-Anti Goat IgG (whole molecule), peroxidase conjugated; Affinity isolated antigen specific 
antibody obtained from rabbit anti‐goat antiserum by immunospecific purification; 
Sigma‐Aldrich, USA; Item # A5420; Western Blotting Dilution 1:1000 
 
-Anti Mouse IgG (Fab specific), peroxidase conjugated; Developed in goat using purified 
mouse IgG Fab fragment as immunogen, the antibody is isolated from goat anti‐mouse IgG 
antiserum by immunospecific purification; Sigma‐Aldrich, USA; Item # A9917; Western 
Blotting Dilution 1:15000 
 
-Anti Rabbit IgG, peroxidase conjugated; Developed in goat using purified rabbit IgG as 
immunogen, the antibody is isolated from goat anti‐rabbit IgG antiserum by immunospecific 
purification; Sigma‐Aldrich, USA; Item # A6154; Western Blotting Dilution 1:1000 
 
2.7.2. Imunnohistochemistry  
 
- Anti Rabbit IgG; Developed in goat using purified rabbit IgG as immunogen, the antibody is 
isolated from goat anti‐rabbit IgG antiserum by immunospecific purification; Cy5; Abcam plc, 
UK, Item: ab6564; IHC Dilution: 1:200 
 
- Anti guinea pig IgG; Developed in goat using purified guinea prg IgG as immunogen, the 
antibody is isolated from goat anti‐guinea pig IgG antiserum by immunospecific purification; 
Alexa Fluor 488; Life Technologies GmbH, Darmstadt, Germany, Item: A-1073; IHC Dilution 
1:200 
 
2.8. Material 
 
-Blotting chamber Trans‐Blot® Semi‐Dry Transfer Cell 
Bio‐Rad Laboratories, USA 
 
-Blotting membrane Immun‐BlotTM PVDF Membrane for Protein Blotting 
Bio‐Rad Laboratories, USA 
 
-Blotting paper Whatman® Gel Blotting Paper 
Schleicher & Schuell, Germany 
 
-Cover‐slips Cover glasses 24 x 50 mm   
VWR International GmbH, Germany 
-Cover‐slips Cover glasses 12 mm   
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Medishop, Möglingen , Germany 
 
-Culture culture dishes 145cm 
Greiner Bio-One GmbH, Frickenhausen, Germany 
 
-Culture culture dishes 10cm 
Greiner Bio-One GmbH, Frickenhausen, Germany 
 
-Curix60 AGFA 
AGFA Healthcare Corporatio, USA 
 
-iCycler Thermocycler 
Bio‐Rad Laboratories, USA 
 
-Gewebe-Homogenisator 
VWR International GmbH, Germany 
 
- HERA safe  
Thermo Fisher Scientific, Deutschland 
 
- SANYO Incubator (MCO-5AC) 
SANYO North America Corporation, USA 
 
-Microplate reader Mithras LB 940 multimode microplate reader 
Berthold Technologies GmbH & Co. KG, Germany 
 
-Microscope Fluorescence Microscope Olympus IX81 
Olympus Deutschland GmbH, Hamburg, Germany 
 
-Microscope slides Microscope slides 76x26 mm 
Menzel GmbH &Co KG, Braunschweig, Germany 
 
-Minigel‐Twin Gel Electrophoresis Apparatus, Minigel‐Twin 
Biometra GmbH, Germany 
 
-NanoDrop NanoDropTM Spectrophotometer ND 1000 
ThermoFisher Scientific, USA 
 
-Photo‐paper Amersham HyperfilmTM ECL 
GE Healthcare UK Ltd, England; 
 
-Powerpac Biometra Standard Power Pack P25 
Biometra GmbH, Germany 
 
-Research Miroscope Olympus BX51 
Olympus Deutschland GmbH, Hamburg, Germany 
 
-Thermomixer 
Eppendorf, Hamburg, Germany 
 
-ube Rotator, STUART® 
Bibby Scientific Limited, Staffordshire, UK 
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2.9. Methods 
 
2.9.1. Mice breeding 
 
tg IRS-2 expressing mice were crossed with CNP driven Cre recombinase expressing mice 
(CNPCre) to ensure oligodendrocyte-specific protein synthesis. Mice not containing the 
transgene IRS-2 or CNPCre were used as controls. These mice were kept in a 12 hour light 
and dark cycle from 7a.m. to 7p.m. They were fed with standard rodent diet.Tg IRS-2 mice 
were made by Dr rer. nat. Udelhoven and present a C57BL/6 background back crossed more 
than 6 generations. CNPCre mice were thankfully provided by Prof Nave, Germany. 
Experiments with the mice were performed in agreement with the German Laws for Animal 
Protection and were approved by the local animal care committee and the Bezirksregierung 
Köln. 
 
2.9.2. Isolation of genomic DNA 
 
Mouse tail biopsies were incubated over night in lysis buffer (tail biopsie lysis buffer and 
500mg/ml proteinase K) in a thermomixer at 55°C. The DNA was then precipitated via 
addition of the equivalent volume of isopropanole. After mixing the lysates were centrifuged 
at 13.000rpm at room temperature for 15 minutes. Supernant was discarded and 150µl 70% 
Ethanol was added. The samples were mixed and centrifuged at 13.000rpm at room 
temperature for 15 minutes. Supernant was discarded, the pellet was dried and resuspended 
in 100mM TrisHCl pH8.  
 
2.9.3. Polymerase chain reaction (PCR) for genotyping 
 
DNA concentrations of tail biopsies lysis were measured with NanoDrop® ND-100 UV 
Spectrophotometer at 260nm. After that the DNA was used to genotype mice for expression 
of CNP driven Cre recombinase and IRS-2 over expression in the ROSA 26 locus. Reactions 
were performed in a Thermocycler PCR machine. All reactions contained not less than 
100ng DNA, 25pmol of each primer (Table 1), 25µM dNTP Mix, 4mM MgCl2, 10% DMSO, 
1xgoTaq reaction buffer and 1 unit of goTaq DNA polymerase. 
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Table 1: Primer sequences of CNPCre and IRS-2 constructs. 
 
PCR programms are presented in table 2. Resulting DNA fragments were used for 
gelelectrophoresis on 2% (w/v) agarose gels (1 x TAE, 0.5 µg/ml ethidium bromide) and 
separated at 120V.  
 
 
Table 2: PCR protocols for CNPCre and IRS-2 constructs. 
 
2.9.4. Brain lysates 
 
The whole brain was lysed in organ lysis buffer via a hand homogenizer. Lysates were then 
mixed on a tube rotator at 4°C for 45 minutes. Afterwards lysates were centrifuged at 
13.000rpm at 4°C. The supernant was added into a new tube and the pellet was discarded.  
Protein levels were measured using the Bradford method. Bradford reagent was diluted 1:5 
and 99µl were added to 1µl of each sample in a 96well plate. Standard curve was generated 
with 0, 1, 2.5, 5 and 10µg of BSA. Detection of protein levels were performed at 600nm via a 
microplate reader. Protein expression levels were analysed with 100µg protein of lysates in 
∞  4°C single   
7min 72°C single   
30sec 72°C     
5min 56°C     
30sec 95°C 35 repeats   
4min 10sec 95°C single CNPCre 
Time Degree Cycle Programm 
∞  4°C single   
7min 72°C single   
2min 72°C     
1min 30sec 60°C     
30sec 95°C 35 repeats   
4min 40sec 95°C single 
antisense ggttagcctttaagcctgcccagaa IRS-2 3´ 
antisense ggtgtagtgggcgatcaggtacttgtg IRS-2 3´ 
sense gactacaaagatgacgacgataa IRS-2 5´ 
sense aatacctttctgggagttctctgctg IRS-2 5´ 
antisense accgtcagtacgtgagatatctt CNPCre 5´ 
antisense ccttcttacacagaacacaagct CNPCre 3´ 
sense cccttcttacacagaacacaagct CNPCre 5´ 
Orientation Sequence Primer 
IRS-2 over 
expression 
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Laemmli buffer. The samples were denatured at 95°C for 5 minutes and then resolved on 
SDS-PAGE. 
 
2.9.5. Myelin isolation 
 
Brain myelin was isolated by sucrose density gradient centrifugation as described by Norton 
(Norton and Poduslo 1973). Briefly, brains were homogenized in 20 lL/mg 0.32 M ice cold 
sucrose and layered over an equal volume of 0.85 M sucrose. After centrifugation 
at 75 000 g for 30 min at 4°C, myelin was collected from the interphase and osmotically 
shocked with water on ice for 30 min. The myelin fragments were sedimented at 20 000 g for 
40 min at 4°C, resuspended in lysis buffer [50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% (v/v) 
NP-40, 5 mM EDTA, 5% (v/v) glycerol,10 lg leupeptin per mL, 10 lg aprotonin per mL, 1 mM 
phenylmethylsulfonylfluoride and 1 mM Na3VO4]. After centrifugation at 16 000 g for 45 min 
at 4°C, supernatant was harvested and protein concentration was measured using the 
method of Bradford (2.9.4). 
 
2.9.6. SDS PAGE 
 
Sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) also called SDS-
PAGE is used to separate proteins with regard to their molecular size. Proteins are 
denatured and linearized by heat and anionic detergent SDS. Such samples are negatively 
charged in proportion to its molecular mass. Samples are supplied to the polyacrylamide gel 
in a gel apparatus (Minigel-Twin) filled with 1xSDS-PAGE running buffer. An electric current 
is applied and the negatively charged proteins migrate through the gel with different speed 
depending on the molecular size of the proteins. Small proteins migrate more easily through 
the gel while larger proteins migrate more slowly. The stacking gel collects the proteins and 
the resolving gel seperates the proteins according to their molecular size. The resolving gel 
shows a contcentration from 8, 10 or 15% acrylamide (Table 5). The different concentrations 
are dependent on the molecular size of the proteins of interest. 8% resolving gels are used 
for proteins with high molecular weight and 15% resolving gels are used for small molecular 
weight proteins. 
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Table 3: SDS-PAGE Gels 8 and 10%(2 mini gels) and 15% (1 mini gel). 
 
Polyacrylamide gels contain the catalyst of polymerization Ammonium-persulfate (APS). 
N,N,N´,N´-tetramethylethylenediamine (TEMED) is added at last to initiate polymerization. 
Samples and 10µl PageRulerTM Prestained Protein Ladder is added to the gel. 
Electrophoresis of samples in the stacking gel is promoted at 120V and in the resolving gel at 
150V. 
 
2.9.7. Western Blot 
 
Western Blot is performed to transfer the seperated proteins on the polyacrylamidegel to a 
polyvinylidene difluoride (PVDF) membrane via electrophoresis with semidry-blotting. An 
electric current transfers the negative charged proteins from the polyacrylamid gel onto the 
PVDF membrane (7x9cm). First three transferbuffer soaked whatman papers (7x9cm) were 
placed on a horizontally localized cathode plate. Then the PVDF membrane was incubated in 
99% methanol for 30sec and put onto the whatman papers. After cutting off the stacking gel, 
the resolving gel is placed on the membrane and covered by three additional transferbuffer 
soaked whatman papers. Air bubbles were removed by carefully rolling over the stack with a 
pipette. Then the anode plate is placed on top of the stack. These two electric plates are 
close to each other because only seperated by the stack to provide a high field strength 
(V/cm) for the protein transfer. 
The transfer was performed with an electric current of about 200 milli-ampere (mA). The time 
of transfer was dependent on the molecular mass of the proteins of interest. Proteins with a 
size up to 100kDa were transferred for 1 hour, proteins with a higher molecular mass  for 1.5 
hours. Afterwards the gel and whatman papers were discarded and the membrane was 
incubated in blocking solution (10% western blocking solution in 1xTBS) for 1 hour at room 
temperature to saturate vacant membrane protein binding sites. Then the membrane was 
incubated with the primary antibody to detect the protein of interest (antibody in 5% western 
blocking solution in 1xTBS) over night at 4°C. Subsequently the membrane was washed four 
times every 15 minutes with 1xTBS consisting of 0.1 % TWEEN 20® (TBS‐T). These 
10.5µl 12µl 12µl 4µl TEMED 
140µl 160µl 160µl 80µl 10% APS 
5.25ml 4ml 3.2ml 680µl 30% Acrylamid  
105µl 120µl 120µl 40µl 10% SDS 
1.3ml 1.5ml 1.5ml   3M TrisHCl 
 
      0.5ml 1M TrisHCl 
 
3.5ml 6.34ml 7.14ml 2.74ml ddH2O 
Resolving Gel 
[15%] 
Resolving Gel 
[10%] 
Resolving Gel 
[8%] 
Stacking Gel Chemicals 
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processes were performed on a rocker at room temperature and removed unbound 
antibodies.  
After that the membrane was added to the secondary antibody solution (antibody in 5% 
western blocking solution in 1xTBS) for 1 hour. The secondary antibody is conjugated to 
horseradish peroxidase (HRP) via protein cross‐linking. Afterwards the membrane was 
washed four times for each 15 minutes with TBS-T. Enhanced chemiluminescence (ECL) 
assay was used to detect proteins of interest with photographic film. β-actin served as 
loading control. For phosphorylated proteins the unsphosphorylated form of the protein 
served as loading control. 
The HRP conjugated to the secondary antibody catalyzes the oxidation of luminol which 
causes light emitting. This light is detected using a photograph film. For this detection 
membrane is incubated in two detecting reagents (Amersham ECL™ Western Blotting 
Detection Reagent), which are mixed. Afterwards the membrane was covered with plastic foil 
and placed into a metal cassette. In a darkroom the membrane was exposed to a 
photosensitive film (AmershamTM Hyperfilm ECL). The time of exposure depended on the 
intensity of emitted light and lasted from 10 seconds to 30 minutes. Then the film was 
developed (CURIX60, Agfa-Gevaert, Sepestraat, Belgium). 
In some cases the PVDF membrane was cleared from antibodies, “stripping” to be incubated 
with an antibody detecting another protein. This was performed once for each blot to obtain 
proper protein detection. The membrane was incubated in stripping solution at 60°C for 20 
minutes in a shaking water-bath. Then the membrane was washed for four times in TBS-T 
followed by blocking (10% western blocking reagent in 1xTBS) for 1 hour at room 
temperature.  Afterwards another primary antibody could be added to the membrane.  
 
2.9.8. Histology  
 
CC mice were crossed with tg IRS-2 mice. Those mice were anesthetized and transcardially 
perfused with physiological saline solution and then with 4% paraformaldehyde (PFA) in 
0.1M phosphate-buffered saline (PBS pH7.4). Brains were incubated in 4% PFA over night 
and then for three days in 20% sucrose in PBS pH7.4 at 4°C. Then brains were frozen in 
tissue-freezing medium (Jung Tissue Freezing Medium; Leica Microsystems, Wetzlar, 
Germany). These samples were axially sectioned via Research Cryostat Leica CM3050 S 
(Leica, Wetzlar, Germany) harvest on slides and stored at -80 °C. 
 
2. Material and Methodes   
  41 
2.9.8.1. Immunohistochemistry  
 
Frozen sections were dried at room temperature and with the PAP pen a hydrophobic barrier 
through was drawn around the section on the slide. Afterwards the slides were rinsed 2-3 
times in PBS to remove frozen mounting media. The slides were then incubated for 10min in 
5% Triton-X and washed for 3 times in PBS for 5min. The primary antibody diluted in 0.8% 
BSA was then put on the sections and incubated for 18h at RT. Afterwards the slides washed 
again in PBS 3 times for 5min and incubated with the secondary antibody diluted in 0.8% in 
BSA for 2h at RT. The slides were then dried and mounted in Fluoromount (Sigma Aldrich, 
Cat. No. F4680, USA). 
 
2.9.8.2. Histological stainings  
 
2.9.8.2.1. Combinational staining of Klüver-Barrera 
 
Frozen sections were dried at room temperature and then washed with distilled water for 30 
seconds. Afterwards sections were stained for 2h at 56°C in Solvent blue-solution, which was 
diluted 1:4 in 96% Ethanol and incubated at room temperature (RT) for 2min in 96% Ethanol, 
2min in 0,01% NaOH (1M) and 1 min in distilled water. Then the sections were stained for 
6min at 56°C in Cresyl violet -solution. Finally sections were differentiated in 96% Ethanol 
and dehydrated in 100% isopropanol, both for 2min. Slides were dried and mounted in 
Entellan (Merck, Catalog # 1079610100, Darmstadt, Germany). 
 
2.9.8.2.2. Nissl staining 
 
Frozen sections were dried at room temperature and then washed with water for 30 seconds. 
Afterwards sections were stained in Nissl staining solution (0.1% Cresyl violet in distilled 
water) for 20 minutes followed by an additional washing step in water for 30 seconds.. Then 
sections were incubated in 40%, then 70%, 95% and at last in 100% ethanol for up to 10 
minutes. Afterwards slides were incubated in Xylol for 5 minutes and additionally in fresh 
Xylol for 2 minutes. Slides were dried and mounted in Entellan (Merck, Catalog # 
1079610100, Darmstadt, Germany).  
 
2.9.9. Behavioral studies  
 
Behavioural studies were performed to test whether an oligodendrocyte specific over 
expression of IRS-2 cause any changes in behaviour and motor coordination. For the 
2. Material and Methodes   
  42 
following tests Wildtype (WT), CNPCre (CC), IRS-2 (IR) and IRS-2 overexpressing (IRCC) 
male and female mice were used.  
 
RotaRod 
 
Mice were placed on a rotating wheel with different speeds and the time was measured until 
the mice fell off the wheels. First the mice had to learn to run on the wheels. After this period 
the measurements were performed at 4, 8, 16rpm and accelerated speed.  
 
Trunk-curl 
 
The Trunk-curl is an analysis of motor coordination. Mice were lifted about 30cm in the air by 
the tail presence or absence of a trunk curl is noted. 
 
2.10. Transformation and Plasmid isolation 
 
Transformation of Cacl2-competent Escherichia coli (Omnimax) was performed to amplify a 
specific vector in shaking culture of 100ml LB-medium followed by isolation of the Plasmid 
(Qiaprep Spin Maxiprep Kit, Qiagen GmbH, Hilden, Germany) or to separate single bacteria 
colonies on a agar plate. Both medium and agar plate contain the specific antibiotic to 
guarantee bacteria growth which include the vector with the specific antibiotic resistance 
gene.  
For transformation of Cacl2-competent E. coli bacteria were incubated at 4
°C with 7µl of the 
ligation reaction added for 25 minutes. After that a heat shock is performed at 42°C for 1.5 
minutes. Then bacteria were harvested at 4°C for 5 minutes followed by addition of 400µl of 
LB-medium. Bacteria were then shaked at 37°C for one hour. Afterwards the bacteria were 
plated on an agar containing kanamycin 25µg/ml and incubated at 37°C overnight in a 
bacteria incubator (BINDER GmbH, Tuttlingen, Germany).  
The next day single bacteria colonies were picked and each added to single tubes with LB-
medium (kanamycin 25µg/ml) and shaken in a bacteria shaker (INFORS AG, Bottmingen, 
Switzerland) at 37°C overnight.  
Plasmids were isolated using the Qiaprep Spin Miniprep Kit (Qiagen GmbH, Hilden, 
Germany) according to the protocol of the manufacturer. The plasmids of the single bacteria 
clones were digested with BamHI and XhoI at 37°C for 1h to identify plasmids which contain 
the target gene. These plasmids were sequenced via T3 and T7 sequencing primers 
(Eurofins MWG Operon, Ebersberg, Germany). Plasmids of clones which showed disruptions 
of the target gene, e.g. like frame shifts were again transformed into Cacl2-competent E. coli, 
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grown in 100ml shaking LB-medium culture followed by isolation of the plasmid (Qiaprep 
Spin Maxiprep Kit, Qiagen GmbH, Hilden, Germany) to obtain an increased amount of 
suitable DNA for further transfection.  
 
Generation of Cacl2-competent E. coli 
 
Cacl2-competent E. coli were grown in 100ml LB-medium at 37
oC overnight in a bacteria 
shaker (INFORS AG, Bottmingen, Switzerland). Then 2ml were added to new 200ml LB-
medium and shaken at 37°C until the culture reached an OD600 of 0.4. Measurements were 
performed with NanoDrop. The bacteria culture was incubated at 4°C for 10 minutes to stop 
growth. Then the culture was centrifuged at 3000rpm at 4°C for 5 minutes. The supernant 
was discarded and bacteria were resuspended in 100ml CaCl2-buffer. Afterwards this 
suspension was incubated at 4°C for 25 minutes and then centrifuged at 3000rpm and 4°C 
for 4 minutes. The supernant was discarded and the pellet was resuspended in 5ml CaCl2-
buffer. Bacteria were separated in 100µl aliquots and harvested at -80°C. 
 
2.11. Generation of stably expressing cells 
 
pCMV-Tag 2C vector containing mouse derived IRS-2 and the pCMV-Tag 2B containing 
human derived IRS-1 (2µg), were linearized with 4 Units SspI for 2 hours at 37°C. 
Transfection of OLN93 cells was performed via Metafectene according to the protocol of the 
manufacturer. OLN93 cell transfected with the empty vector were used as controles (EV). 
Cells were treated with selection medium containing 2mg/ml G418 (Sigma‐Aldrich Chemie 
GmbH, Steinheim, Germany) for two days after transfection. Single cells were separated on 
96-well plates after 2 weeks of selection with G418 and cultured in 0,3mg/ml G418. Cell 
clones were tested for expression of IRS-2 and IRS-1, positive clones were used for further 
experiments. After that cells were grown without G418. 
 
2.12. PCR T7 Primer 
 
DNA concentrations were measured with NanoDrop® ND-100 UV Spectrophotometer at 
260nm. After that the targeted DNA was tested for amplification. Reactions were performed 
in a Thermocycler PCR machine. All reactions contained not less than 100ng DNA, 25pmol 
of each primer (Table 1), 25µM dNTP Mix, 4mM MgCl2, 10% DMSO, 1xgoTaq reaction buffer 
and 1 unit of goTaq DNA polymerase. 
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Table 4 : Primer sequences of CNPCre T7-Promotor sequence. 
 
PCR programm is shown in table 5. Resulting DNA fragments were used for 
Gelelectrophoresis on 2% (w/v) agarose gels (1 x TAE, 0.5 µg/ml ethidium bromide) and 
separated at 120V.  
 
 
Table 5: PCR protocol for T7-Promotor PCR 
 
2.13. Cell lysates 
 
For whole cell lysates, cells were twice washed with PBS and then incubated at -80°C for 30 
minutes. After that cell lysis buffer was added to the cells (100µl for 10cm plates and 150µl 
for 15cm plates). Then cells were scraped from the culture dishes via cell scraper (Greiner 
Bio-One GmbH, Frickenhausen, Germany), incubated at 4°C for 30 minutes and needeled. 
Afterwards cell lysates were centrigufed at 13.000rpm and 4°C for 30minutes. Supernant 
was added into a new tube and the pellet was discarded. The protein concentration was 
measured using the Bradford method.  
 
2.14. Proliferation assay 
 
Proliferation assay was performed with 100.000 cells per well of each cell line. For IRS-1 and 
IRS-2 stably overexpressing cells 2 clones were analyzed. First cells were counted using the 
Neubauer Zählkammer and 1000 cells were put into a well of a 96-well plate. The next day 
cells were starved in a medium without FBS for 3 days to stop cell proliferation. After that a 
medium with 10% FBS was added for 48 hours. For inhibition of the PI3K and MAPK 
pathway the following inhibitors were used (LY294002: PI3K-inhibitor: 20µM; PD98059: 
MAPK-inhibitor: 50µM) and were added next for 12h, before BrDU was put onto the cells for 
∞  4°C single   
10min 72°C single   
5min 72°C     
45sec 56,5°C     
1min 95°C 40 repeats   
5min 95°C single T7-Promotor 
Time Degree Cycle Programm 
sense attaaccctcagtaaaggga T3-Promotor 
sense taatacgactcactataggg T7-Promotor 
Orientation Sequence Primer 
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12h. Subsequently the proliferation assay (BrdU assay, Millipore, Billerica, MA, USA, item 
#HCS201) was performed according to the protocol of the manufacturer. 
 
2.15. Cell differentiation 
 
To promote differentiation, OLN-93 cells were seeded at low density on 15cm plates (0.6 x 
106 cells) and cultured in DMEM with 10% FCS. After overnight attachment, cells were gently 
washed and subsequently cultured in serum-free DMEM for 6 days [Van Meteeren et al., 
2005] 
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3. Results 
 
Multiple sclerosis (MS) is an inflammatory demyelinating disease that attacks the brain, 
spinal cord and optic nerves in the CNS, but skips the nerve roots and peripheral nerves of 
the peripheral nervous system (PNS). Axonal loss is an unstoppable result from MS and 
might be the pathological correlate for the irreversible neurological impairment of this disease 
[Ferguson, Matyszak, Esiri and Perry, 1997; Lovas et al., 2000; McGavern et al., 2000; Trapp 
et al., 1998]. However oligodendrocytes progenitors are present in MS lesions but they fail to 
remyelinate the affected regions [Scolding 1998; Wolswijk; 1995; Wolswijk; 2000]. 
Oligodendrocytes support axonal function and survival throughout life, independent of myelin 
function [Trapp et al., 1998; Wujek et al., 2002]. The InR/ IGF1R-signaling cascade is known 
to be an fundamental player in myelination, as it acts as a survival factor for oligodendrocytes 
as well as their OPCs  [Barres et al., 1992; Mason et al., 2000; McMorris et al., 1986; Ye and 
D’Ercole, 1999] and stimulates the synthesis of myelin [Roth et al., 1995]. Animal studies 
showed that over expression of IGF-I increases myelin content [Carson et al., 1993; Ye et al., 
1995] and deletion of IGFI strongly decreases myelination and the number of OPCs [Beck et 
al., 1995]. 
As the IRS proteins are important signaling molecules in the IR/ IGF1R our group 
investigated their role for myelination. Previous work showed, that IRS-2 is critical for 
appropriate initiation of myelination, but not for myelin maturation and IRS-1 can only partly 
compensates for the loss of IRS-2. Furthermore IRS-2 knockout mice displayed a smaller 
brain size compared to their littermates, which might reflect myelination as well. On the other 
hand mice lacking the InR revealed no changed or altered myelination, so that the 
myelination initiation signal is mainly transduced via the IGF1R [Freude et al., 2008]. 
Wether increased IRS-2 signaling impacts myelination in vivo is still unknown. Thus the 
following thesis aims to elucidate the influence of IRS-2 on myelination and the InR-/ IGF1R 
signaling in oligodendrocytes. 
Therefore we generated mice which own a floxed westphale stop cassette that regulates an 
IRS-2 gene in the Rosa26 locus (IR). These mice were crossed with mice expressing the 
CNP driven Cre recombinase (CC) to guarantee an oligodendrocyte-specific over expression 
of IRS-2 (IRCC) (Fig. 10). 
CNP (-/-) are known to show normal myelin assembly, whereas the ultrastructure and 
physical stability are not visibly changed. Aside throughout the white matter axons developed 
abnormal swellings and were progressively which leaded to premature death mostly before 
one year of age. Additionally, it can not be excluded that axon functions are changed in the 
motor system of those mice during aging. Therefore those mice present a usable MS model 
[Lappe-Siefke et al., 2003].  
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Figure 10: Breeding strategy of oligodendrocyte-specific over expressing IRS-2 mice. 
Mice with IRS-2 inserted in the Rosa26 locus were crossed with CNP promoter driven Cre recombinase 
expressing mice. Presented below are the locations of the PCR Primers, those generate an allele specific PCR. 
 
3.1. Validation of IRCC mice 
 
The IRS-2 insert in the Rosa26 locus was detected via the IRS-2 specific PCR (2.9.3.). 
Primer 1 and 2 bind forward and 3 and 4 reverse to the DNA sequence. As 1 and 4 bind onto 
the sequence of the Rosa26 locus, the result is a WT specific PCR fragment (Fig.10). 
Similary primer 2 and 3, as this sequence does not exist in WT mouse the fragment is 
particular detectable in transgenic mice. The amplified fragment of IR shows a size of about 
450bp and of a WT mouse 200bp (Fig.11A). For the CC mouse was as well an allele specific 
PCR was designed. Here Primer 1 binds forward in the DNA sequence of the CNP gene and 
2 reverse. Primer 2 binds in case the CNP gene is not deleted (due to insertion of Cre 
recombinase). The Cre recombinase is detected via Primer 3, which binds in a reverse 
orientation (Fig.11). Therefore two bands result in heterozygous mice, a WT fragment about 
450bp and the transgenic fragment about 750bp (Fig. 11A). 
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Figure 11: Validation of IRCC and CC mice. 
(A) IR and CC specific PCR products separated on a 2% agarose gel (2.9.3.). The IR transgenic fragment shows 
a size of about 450bp, whereas the WT is about 200bp. CC transgenic fragment is 750bp and the WT 450bp. 
(B) Immunological staining of eGFP in the corpus callosum of 8 week old IRCC mice and wild type mice as 
controls, show an eGFP expression in IRCC but not in the WT mouse. 
(C) Western-Blot detection of eGFP of 200µg whole brain lysate of 8 week old mice shows an eGFP expression in 
male and female IRCC mice and none in female and male WT mice ( 12 SDS-PAGE gel). 
 
Immunohistochemical staining (Fig. 11B) showed an expression of eGFP in IRCC mice in the 
corpus callosum. There was no eGFP detected in the WT mouse brains. Expression of eGFP 
was proven in both genders  (Fig. 11C).  
 
3.2. Characterisation of IRCC mice 
 
Previously, it has been shown using IRS-2 (-/-) mice that IRS-2 plays a critical role in 
appropriate initiation of myelination, but not in myelin maturation. Therefore IRCC mice were 
analyzed in an age-dependent manner detecting changes of morphology, structure, myelin 
specific protein expression and InR/ IGF1R signaling in the brain. Furthermore 
motorcoodination, body weight and body brain ratio was as well probed. 
 
3.2.1. Body weight and brain body ratio of IRCC mice 
 
The body weight, length and brain weight were measured over the time from day 5 until day 
140 of all different genotypes and both genders to evaluate the body mass index (BMI) and 
the brain body ratio of the mice. 
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The BMI was similar in all genotypes of female mice from 5days up to 140 days of age. All 
four genotypes showed an increase of the BMI from 17,4 at day 5 to 23,6 at day 140 
(Fig.12).  
 
 
 
Figure 12: BMI of female mice. 
BMI of female WT (n=5-15; blue), CC (n=5-19; orange), IR (n=3-14; green) and IRCC (n=3-17; pink) until 140days 
(40weeks) of age. 
 
Male mice showed compared to female mice a higher BMI. The timely pattern is similar to 
female mice, a drop until 15,7 at day 14 which is followed by a gain to 29,5, at day 140 
(Fig.13). 
 
Figure 13: BMI of male mice. 
BMI of male WT (n=5-26; blue), CC (n=7-13; orange), IR (n=6-14; green) and IRCC (n=4-12; pink) until 140days 
(40weeks) of age. 
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Next the brain body ratio of all different genotypes during postnatal development was 
investigated to detect any genotype-specific changes during development. Female mice of all 
genotypes showed a similar plot, which starts at about 6.5%, followed by a decrease and a 
stagnancy from 35 days until 140 days up to about 2% (Fig. 14). 
 
 
 
Figure 14: Brain body ratio of female mice 
Body brain ratio of female WT (n=5-15; blue), CC (n=5-19; orange), IR (n=3-14; green) and IRCC (n=3-17; pink) 
until 140days (40weeks) of age. 
 
Male mice of all genotypes indicated the same pattern as the female mice. However at 5 
days of age WT, IR and IRCC mice start around 6.5%, whereas CC mice displayed a 
reduced brain body ratio by 4,2%. Going further down with age in all genotypes 
demonstrated the same course as females (Fig. 15). 
 
Figure 15: Body brain ratio of male mice. 
BMI of male WT (n=5-26; blue), CC (n=7-13; orange), IR (n=6-14; green) and IRCC (n=4-12; pink) until 140days 
(40weeks) of age. 
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3.2.2. Behaviour of IRCC mice 
 
Motor coordination was investigated via RotaRod. A mouse was put on a rotating wheel with 
different speed and the time was measured until the mouse falls down. This gives a hint 
whether the specific mouse displays an affected motor coordination. For this test adult mice 
(week 12) were tested (Fig.16). Female CC (-/-) (homo CC) mice showed a reduced ability to 
stay on the rod at 16rpm. However no differences were observed comparing the other 
genotypes. 
Accelerating wheel speed did not result it any alternations of IRCC mice. In male mice CC 
and CC (-/-) mice showed a tendency to decrease performance at 16rpm. At accelerating 
speed no differences between the different genotypes were observed. 
 
 
 
Figure 16: RotaRod of 12 weeks old mice 
The RotaRod test male and female WT (n=3, blue), CC (n=3, orange), CC homozygous (CC homo; n=3, red), IR 
(n=3, green) compared to IRCC animals (n=3, pink). Animals were 12 weeks old. 
 
 
Additionally neuromuscular functions were measured via grip strength. An individual mouse 
grabbed a trapeze with its forepaws, and then a horizontal backwards pull was applied until 
the pulling force overcomes its grip strength. Maximal grip strength was measured.  
Female CC, CC (-/-) and IRCC mice displayed an decrease in grip strength compared to IR 
and WT mice. No differences were observed within the different male genotypes (Fig. 17). 
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Figure 17: Grip strength of 12 weeks old mice 
The Grip strength of male and female WT (n=3, blue), CC (n=3, orange), CC homozygous (CC homo; n=3, red), 
IR (n=3, green) compared to IRCC animals (n=3, pink). Animals were 12 weeks old. 
 
 
Due to the lack of enough female and male mice of week 40, individual mice off all 
genotypes and genders were observed during the Trunk-curl. The Trunk-curl is the ability of 
mice to bring the upper body up and a sit up movement when held by the tail. Whereas 
twisting the upper body sideways is not defined as a Trunk-Curl.  
Female and male WT and IR mice were able to bend properly upwards (Fig.18). CC and CC 
homo mice of both genders did not manage to move their body upwards and stretch their 
hind paws backwards, whereas the CC homo mice compared to the CC mice showed a 
stronger phenotype. IRCC mice of both genders displayed similar behaviour as the CC mice, 
but less severe compared to CC homo mice. 
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Figure 18: Trunk-curl of 40 weeks old mice 
The Trunk-curl test analyses the ability of the mouse to bend upwards, when held downwards. Tested were 
female and male WT, IR, CC, CC homo and IRCC mice at week 40. 
 
 
3.2.3.1. Morphological and structural brain analysis of IRCC mice 
 
Perfused brains for female and male mice of all genotypes were sliced in coronal sections 
and examined in respect to changes in morphology and structure of the brain. 
Nissl-staining stains the negatively charged RNA blue and highlights important structural 
features of neurons. The Nissl substance appears dark blue as it represents the granular 
cytoplasmic reticulum and ribosomes, which gives the cytoplasm a mottled appearance. DNA 
present in the nucleus is stained blue. The second method, Klüver-Barrera-staining is a 
combination to demonstrate myelin and Nissl substance respectively. Myelin and 
phospholipids appear blue to green whereas cells and cell products are pink to violet. 
Slices of week 12 mice of all genotypes showed no difference in morphological and structural 
appearance of the brain. There were no discrepancies in the structure of the white (as corpus 
callosum) or grey matter (as cerebellum). Equally myelin and phospholipids staining via 
Klüver-Barrera-staining displayed no differences between the different genotypes. The white 
matter, as the corpus callosum displayed no structural or morphology changes (Fig. 19). 
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Figure 19: Nissl-staining and Klüver-Barrera-staining of W12 mice 
Perfused brains were sliced coronoal in 20µm slices. Those were stained by Nissl-staining and Klüver-Barrera-
staining. Shown are brain slices of male WT, CC and IRCC mice. The left row give an overview and the 
enlargement focuses onto the corpus callosum. 
 
 
Going downwards in age week 8 female and male mice of all genotypes demonstrated no 
structural abnormalities compared to each other. Nissl-staining and Klüver-Barrera-staining 
showed the same appearance of white and grey matter, in the hippocampal formation, the 
corpus callosum and the cerebral cortex. There were no age dependent morphological 
chances in the formation of the different brain regions, as the corpus callosum, hippocampal 
formation and cerebral cortex indicated an unaltered brain development (Fig. 20). 
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Figure 20: Nissl-staining and Klüver-Barrera-staining of W8 mice 
Perfused brains were sliced coronoal in 20µm slices. Those were stained by Nissl-staining and Klüver-Barrera-
staining. Shown are brain slices of male WT, CC and IRCC mice. The left row give an overview and the 
enlargement focuses onto the corpus callosum. 
 
 
Sections of female and male mice of all genotypes at week 5 revealed no structural or 
morphological changes as well. The corpus callosum was completely normal structured in all 
genotypes. There were no differences in the cortex or the hippocampal formation detected. 
Morphologically and structurally all brains were not altered, due to the transgenic IRS-2 over 
expression or heterozygous CNP gene deletion (Fig. 21). 
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Figure 21: Nissl-staining and Klüver-Barrera-staining of W5 mice 
Perfused brains were sliced coronoal in 20µm slices. Those were stained by Nissl-staining and Klüver-Barrera-
staining. Shown are brain slices of male WT, CC and IRCC mice. The left row give an overview and the 
enlargement focuses onto the corpus callosum. 
 
 
3.2.3.1. Immunohistochemical analysis of myelination in IRCC mice 
 
Histochemically no differences were observed (Fig.10-12) in all genotypes at week 12, 8 and 
5. As those staining methods can give only a general impression about morphology and 
structure, those brain slices were also immunohistochemically stained against two myelin 
specific Proteins, MBP and PLP. Those should give the opportunity to get a more detailed 
insight into the structure of myelination in the brain of WT, CC and IRCC mice. 
However, staining using antibodies against MBP and PLP revealed in CC and IRCC mice 
compared to the WT no differences at the age of week 12. The corpus callosum showed the 
same protein expression pattern in all genotypes (Fig.22). 
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Figure 22: Immunohistochemical staining of MBP and PLP at the age of 12 weeks 
Perfused brains were sliced coronoal in 20µm slices. Those were stained using antibodies against MBP (1:500) 
and PLP (1:100). Shown are brain slices of male WT, CC and IRCC mice.  
 
 
At week 8 brains of female and male mice of all genotypes were immunohistochemically 
stained using antibodies of the proteins MBP and PLP. Staining against MBP and PLP 
revealed no differences in CC and IRCC mice compared to the WT (Fig.23). 
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Figure 23: Immunohistochemical staining of MBP and PLP at the age of 8 weeks 
Perfused brains were sliced coronoal in 20µm slices. Those were stained using antibodies against MBP (1:500) 
and PLP (1:100). Shown are brain slices of male WT, CC and IRCC mice.  
 
 
5 weeks old brains of female and male mice all genotypes were immunohistochemically 
stained using antibodies of the proteins MBP and PLP. MBP as well as PLP staining 
revealed no changes of protein expression or distinctions in the white matter structures like 
corpus callosum, compared to thedifferent genotypes (Fig.24). 
Heterozygous knockout of CNP as well as the oligodendrocyte over expression of IRS-2 
showed no effect on MBP and PLP expression in the brain (Fig.22-24) 
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Figure 24: Immunohistochemical staining of MBP and PLP at the age of 5 weeks 
Perfused brains were sliced coronoal in 20µm slices. Those were stained using antibodies against MBP (1:500) 
and PLP (1:100). Shown are brain slices of male WT, CC and IRCC mice.  
 
 
3.2.4. Quantity of myelin specific proteins 
 
Mice of all four genotypes were sacrificed at different time points, to investigate myelin 
protein composition. Out of those brains, myelin was isolated via sucrose density gradient 
centrifugation as described by Norton (Norton and Poduslo 1973) (2.9.7) and analysed via 
SDS-PAGE and Western Blot to get a more detailed insight into myelin protein composition. 
 
Comparison of CNP amount in the four different genotypes showed a strong reduction in the 
expression in female and male IRCC mice at the age of 20 weeks. Female and male WT, IR 
and CC mice displayed the same amount of CNP. Heterozygous CC mice of both genders 
displayed the same protein level of CNP at this time point when compared to WT and IR 
mice. 
PLP and its splice variant DM20 as well as MBP did not show any differences between the 
genotypes (Fig.25). 
Coomassie staining of the SDS-PAGE gel displayed an equal gel loading. 
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Figure 25: Myelin specific protein expression of mice 20 weeks of age 
Myelin was isolated using a sucrose gradient centrifugation and separated via 15% SDS-PAGE gel. Detection of  
of CNP, PLP/DM20 and MBP was performed using 50µg protein lysate of female and male WT, IR, CC and IRCC 
mice at 20 weeks of age. Coomassie staining was performed as loading control of the SDS-PAGE gels. 
 
 
Analysis of week 12 old mice showed no changes in CNP protein expression level in all four 
genotypes and both genders. Heterozygous Female and male CC mice did not display 
reduced CNP content at this timepoint compared to WT, IR and IRCC mice of both genders. 
PLP, DM20 and MBP protein amount in female and male mice of all genotypes diplayed no 
difference (Fig.26)  
Coomassie staining of the SDS-PAGE gel showed an equal loading. 
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Figure 26: Myelin specific protein expression of mice 12 weeks of age 
Myelin was isolated using a sucrose gradient centrifugation and separated via 15% SDS-PAGE gel. Detection of  
of CNP, PLP/DM20 and MBP was performed using 50µg protein lysate of female and male WT, IR, CC and IRCC 
mice at 12 weeks of age. Coomassie staining was performed as loading control of the SDS-PAGE gels. 
 
 
Myelin isolation of 8 weeks old mice showed the same CNP protein content in all gebotypes. 
Heterozygous CC mice, did not display a reduced CNP content at this time point in isolated 
myelin samples compared to WT, IR and IRCC mice of both genders. 
PLP and DM20 protein amount in all genders and genotypes was the same. The protein 
quantity of MBP indicated equal expression levels in all lines (Fig.27). 
Coomassie staining of the SDS-PAGE gel displayed an equal loading of the protein samples 
of the two genders and different genotypes. 
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Figure 27: Myelin specific protein expression of mice 8 weeks of age 
Myelin was isolated using a sucrose gradient centrifugation and separated via 15% SDS-PAGE gel. Detection of  
of CNP, PLP/DM20 and MBP was performed using 50µg protein lysate of female and male WT, IR, CC and IRCC 
mice at 8 weeks of age. Coomassie staining was performed as loading control of the SDS-PAGE gels. 
 
 
At 5 weeks of age isolated myelin of female and male WT, IR, CC and IRCC mice displayed 
an equal expression level of CNP.  
Protein amount of PLP, DM20 and MBP in isolated myelin showed no strong alterations at 
this time point in both genders and in all four genotypes (Fig.28). 
Coomassie staining of the SDS-PAGE gel revealed equal loading of isolated myelin proteins. 
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Figure 28: Myelin specific protein expression of mice 5 weeks of age 
Myelin was isolated using a sucrose gradient centrifugation and separated via 15% SDS-PAGE gel. Detection of  
of CNP, PLP/DM20 and MBP was performed using 50µg protein lysate of female and male WT, IR, CC and IRCC 
mice at 5 weeks of age. Coomassie staining was performed as loading control of the SDS-PAGE gels. 
 
Isolated myelin at week 3 of female and male WT, IR, CC and IRCC mice displayed a slight 
reduced amount of CNP in both genders of WT mice compared to IR, CC and IRCC mice. 
CNP amount of female and male IR, CC and IRCC mice compared to each other was similar. 
Heterozygous CNP mice had the same CNP content as female and male IR and IRCC mice 
at this time point. 
PLP and DM20 protein expression was in female mice of all genotypes the strongest and 
displayed to be similar. 
Female mice expressed more protein of the 21.5kDa MBP isoform, which is known to appear 
earlier in development of mice. IRCC mice of both genders mice showed to have the highest 
protein levels of all MBP isoforms (21.5, 18.5, 17, 14kDa). The expression level of the 18.5 
and 17kDa isoform in CC mice is nearly similar to the one in IRCC mice.  
Coomassie staning of the SDS-PAGE gel revealed a equal loading (Fig.29).  
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Figure 29: Myelin specific protein expression of mice 3 weeks of age 
Myelin was isolated using a sucrose gradient centrifugation and separated via 15% SDS-PAGE gel. Detection of  
of CNP, PLP/DM20 and MBP was performed using 50µg protein lysate of female and male WT, IR, CC and IRCC 
mice at 3 weeks of age. Coomassie staining was performed as loading control of the SDS-PAGE gels. 
 
 
At day 5 of age CNP abundance in isolated myelin showed slight variations which were not 
dependent on the genotype. 
DM20 protein levels was not detectable, even when 500µg protein amount were loaded.  
Protein content of MBP isoforms were similar in both genders of WT, IR and IRCC mice. 
Male CC and WT displayed elevated levels of the 18.5, 17 and 14kDa isoform. The other 
mice indicated comparable amount of the 18.5, 17 and 14kDa isoform. 
Coomassie staning of the SDS-PAGE gel revealed equal protein content (Fig.30).  
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Figure 30: Myelin specific protein expression of mice 5 days of age 
Myelin was isolated using a sucrose gradient centrifugation and separated via 15% SDS-PAGE gel. Detection of  
of CNP and MBP was performed using 50µg and PLP/ DM20 using 400µg protein lysate of female and male WT, 
IR, CC and IRCC mice at 5 days of age. Coomassie staining was performed as loading control of the SDS-PAGE 
gels. 
 
 
3.2.5. InR/ IGF1R signaling in IRCC mice 
 
The InR and IGF1R signaling pathway, as well as myelin specific proteins and some 
components of the Wnt signaling pathway were analysed time dependently in female and 
male WT, IR, CC and IRCC mice via western-blot. 
At the age of week 20 the expression of the IGF1R was similar in female and male WT, CC, 
IR and IRCC mice. The expression levels of InR were comparable to each other in both 
genders and all four genotypes. The protein GFP was as expected only found in female and 
male IRCC mice and the actin control showed equal loading of protein amount (Fig.31 A). 
Downstream of the InR and IGF1R, it could be observed at this time point that AKT 
phosphorylation showed no difference between the genotypes. AKT protein amount was 
euqal in both genders and all four genotypes.  
ERK 1 and 2 phosphorylation was not different between the genotypes. ERK 1 and 2 protein 
amount was similar in all genotypes. 
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GSK3α and β phosphorylation showed no differences between female and male mice of the 
different genotypes, as well as GSK3β expression (Fig 31 B). 
In chronic MS especially MMP-7 and MMP-9 protein levels are elevated [Cossins et al., 
1997]. Next to this activated T cells trigger the release of proinflammatory cytokines, such as 
TNFα and interferon-γ by inflammatory cells, macrophages and mikroglia in MS [Brosman 
and Raine; 1996]. Therefore, inflammatory protein expression levels of MMP-9 and TNFα 
were as well analysed. 
MMP-9 protein amount was similar in WT, CC, IR and IRCC mice. TNFα content was equal 
in female and male WT, IR and female CC mice. In male CC and female IRCC mice, but 
more pronouced in male IRCC mice protein expression of TNFα was sightly upregulated 
(Fig. 31C). 
 
 
Figure 31: InR/ IGF1R signaling pathway and inflammatory proteins in female and male WT, IR, CC and IRCC 
mice at 20 weeks of age 
(A) IGF1R, InR and GFP expression levels are shown. Actin served as control.  
(B) Phosphorylation of AKT (pAKT, Ser473), ERK1/2 (pERK1/2, Thr202/Tyr204) and GSK3αβ (pGSK3α, Ser 
21/pGSK3β, Ser9) are shown. As control served unphosphorylated protein level of AKT, ERK1/2 and GSK3β 
(C) MMP-9 (upper band) and TNFα protein expression are shown. Actin served as control. 
100 µg of total proteins were used and separated via 10% SDS-PAGE in A, B and C. 
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Myelin specific protein expression and the analysis of Fyn kinase, which is known to be 
involved in myelination, in mice at 20 weeks of age showed an equal expression of the 
unphosphorylated active form of the Fyn kinase in female and male mice of all four 
genotypes.  
CNP expression levels were similar in male WT, female CC, IR and IRCC mice of both 
genders (Fig. 32). 
 
 
Figure 32: Myelin specific protein and Fyn kinase expression in female and male WT, IR, CC and IRCC mice at 
20 weeks of age. 
Fyn kinase, CNP, and MBP expression levels are shown. Actin served as control. 100µg of total protein were 
used and separated via 10% and 15% SDS-PAGE gel. 
 
 
Analysis of protein expression of proteins of the Wnt signaling pathway showed similar β-Cat 
phosphorylation in male CC, female and male IR and IRCC mice.  
Wnt5a, the opponent of Wnt3 in the Wnt signaling cascade, expression was equal in both 
genders and all genotypes at 20 weeks of age. Actin protein levels were all equal of all 
genotypes (Fig.33). 
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Figure 33: Wnt signaling pathway in female and male WT, IR, CC and IRCC mice at 20 weeks of age. 
Phosphorylation of β-Catenin (p-β-Cat, Ser33, Ser 37 and Thr41), β-Catenin and Wnt5a protein levels are shown. 
Actin served as control. 100µg of total protein were used and separated via 10% SDS-PAGE gel. 
 
 
InR and IGF1R signaling pathway analysis of mice at week 12 of age, showed similar protein 
expression of IGF1R in male WT, female and male IR and CC mice. Reduced protein 
content could be found in female WT, female and male IRCC mice compared to the other 
mice. 
InR expression levels were identically in female and male mice of all genotypes. 
GFP protein was only detectable in female and male IRCC mice. Control of protein loading, 
i.e. actin content was equal in both genders and all genotypes (Fig.34 A). 
Phosphorylation of AKT and AKT protein content showed no differences. 
ERK1 and 2 phosphorylation was similar in female WT, female CC, female and mal IR and 
IRCC mice. ERK1 and 2 protein amount as control showed equal ERK1 and ERK2 
concentrations.  
Phosphorylation of GSK3β were similar in both genders and all genotypes. GSK3β protein 
amount was unaltered (Fig.34 B). 
MMP-9 protein expression was increased in female and male CC and IRCC mice compared 
to the other genotypes. 
TNFα, showed increased expression levels in female WT, female IR and both genders of 
IRCC mice in respect to the other genotypes.  
Control of equal protein loading revealed similar gel loading of all samples (Fig.34 C). 
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Figure 34: InR/ IGF1R signaling pathway in female and male WT, IR, CC and IRCC mice at 12 weeks of age 
(A) IGF1R, InR and GFP expression levels are shown. Actin served as control.  
(B) Phosphorylation of AKT (pAKT, Ser473), ERK1/2 (pERK1/2, Thr202/Tyr204) and GSK3αβ (pGSK3β, Ser9) 
are shown. As control served unphosphorylated protein level of AKT, ERK1/2 and GSK3β 
(C) MMP-9 and TNFα protein expression are shown.  
Actin served as control.100 µg of total proteins were used and separated via 10% SDS-PAGE in A, B and C. 
 
 
Analysis of Fyn kinase expression revealed no differences in the protein expression. 
The myelin specific protein CNP was similar expressed in both genders of WT, IR and 
female CC mice, with an increase in male CC and the lowest in female and male IRCC mice. 
Protein amount of MBP was unaltered in both genders and in those four genotypes. 
Expression levels of PLP compared in female and male mice of WT, IR, CC and IRCC 
showed no changes due to gender or genotype. 
Protein loading control, i.e. actin indicated equal loading of protein amount (Fig. 35). 
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Figure 35: Myelin specific protein and Fyn kinase expression in female and male WT, IR, CC and IRCC mice at 
12 weeks of age. 
Fyn kinase, CNP, MBP and PLP expression levels are shown. Actin served as control. 100µg of total protein were 
used and separated via 10% and 15% SDS-PAGE gel. 
 
 
Protein amount of IGF1R and InR was similar in both genders of WT, IR, CC and IRCC mice.  
GFP protein expression was only found in female and male IRCC mice and protein loading 
reveals equal protein quantity (Fig. 36 A). 
Downstream of the InR/ IGF1R signaling cascade AKT phosphorylation was similar in both 
genders of WT, IR, CC and IRCC mice. AKT protein content was similar in both genders and 
all genotypes. 
ERK1 and 2 phosphorylation was unchanged in female and male mice of all genotypes, as 
well as ERK1 and 2 protein levels. 
GSK3α/β phosphorylation showed no variations. GSK3β protein concentration was equal in 
both genders and all genotypes (Fig. 36 B). 
MMP-9 expression levels were similar in female and male mice of all genotypes. TNF α 
protein expression was identical in female and male WT, IR and IRCC mice, reduced in both 
genders of CC mice. Actin protein content displayed to be unaltered in female and male mice 
of all genotypes (Fig. 36 C). 
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Figure 36: InR/ IGF1R signaling pathway in female and male WT, IR, CC and IRCC mice at 8 weeks of age 
(A) IGF1R, InR and GFP expression levels are shown. Actin served as control.  
(B) Phosphorylation of AKT (pAKT, Ser473), ERK1/2 (pERK1/2, Thr202/Tyr204) and GSK3αβ (pGSK3β, Ser9) 
are shown. As control served unphosphorylated protein levels of AKT, ERK1/2 and GSK3β 
(C) MMP-9 and TNFα protein expression is shown. Actin served as control. 
100 µg of total proteins were used and separated via 10% SDS-PAGE in A, B and C. 
 
 
Fyn kinase protein expression was equal in female and male WT, IR, CC and IRCC mice. 
Myelin specific protein expression, as CNP and MBP revealed similar protein expression 
throughout both genders and all genotypes. PLP protein content was equal in female and 
male WT, IR and CC mice and slightly decreased in both genders of IRCC mice. DM20 
protein expression levels were similar in female and male WT, CC and IRCC mice, and 
marginally reduced in both genders of IR mice.  
Actin Western Blot revealed equal protein loading of female and male samples of all 
genotypes (Fig. 37). 
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Figure 37: Myelin specific protein and Fyn kinase expression in female and male WT, IR, CC and IRCC mice at 8 
weeks of age. 
Fyn kinase, CNP, MBP and PLP expression levels are shown. Actin served as control. 100µg of total protein were 
used and separated via 10% and 15% SDS-PAGE gel. 
 
 
InR and IGF1R signaling pathway analysis of mice at week 5 of age using Western Blots, 
showed similar protein expression of IGF1R in male WT, female and male IR, IRCC and 
female CC mice. Reduced protein content was found in female WT and male CC mice 
compared to the other genotypes and genders. 
InR expression levels were similar in females and males of all genotypes. 
GFP protein was only found in female and male IRCC mice. 
Control of protein loading, i.e. actin content was equal in both genders of all genotypes 
(Fig.38 A). 
AKT phosphorylation was in female and male mice of all genotypes similar. AKT protein 
content showed no difference. 
ERK1 and 2 phosphorylation was unaltered in all genotypes as well as ERK1 and 2 protein 
amount.  
GSK3α/β phosphorylation was similar in both genders and all genotypes. GSK3β protein 
amount as control of protein loading was unchanged in all genotypes as well (Fig.38 B). 
Protein content of MMP-9 displayed no consistent changes within the different genotypes. 
TNFα, showed increased expression levels in female and male WT and IR mice. Reduced 
levels could be found in both genders of CC and IRCC mice.  
Control of equal protein loading showed similar protein content of each sample (Fig.38 C). 
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Figure 38: IR/ IGF1R signaling pathway in female and male WT, IR, CC and IRCC mice at 5 weeks of age 
(A) IGF1R, InR and GFP expression levels are shown. Actin served as control.  
(B) Phosphorylation of AKT (pAKT, Ser473), ERK1/2 (pERK1/2, Thr202/Tyr204) and GSK3αβ (pGSK3β, Ser9) 
are shown. As control served unphosphorylated protein level of AKT, ERK1/2 and GSK3β 
(C) MMP-9 and TNFα protein expression is shown. Actin served as control. 
100 µg of total proteins were used and separated via 10% SDS-PAGE in A, B and C. 
 
 
Analysis of myelin specific protein expression and Fyn kinase, revealed similar expression 
levels in females and males of all genotypes. 
Myelin specific proteins as CNP showed equal protein levels in all genotypes. 
MBP protein content was similar in female and male WT, IR and female CC mice, a bit lower 
levels were found in male CC and both genders of IRCC mice.  
PLP and DM20 protein expression was equal in female and male WT, IR and CC mice, and 
slightly increased in both genders of IRCC mice (Fig. 39). 
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Figure 39: Myelin specific protein and Fyn kinase expression in female and male WT, IR, CC and IRCC mice at 5 
weeks of age. 
Fyn kinase, CNP, MBP and PLP expression levels are shown. Actin served as control. 100µg of total protein were 
used and separated via 10% and 15% SDS-PAGE gel. 
 
 
InR and IGF1R signaling pathway analysis of mice at week 5 of age, showed similar protein 
expression of IGF1R in female and male mice of WT, IR, CC and IRCC.  
InR expression levels were similar in female and male mice of all genotypes. 
GFP protein was only detected in female and male IRCC mice.  
Control of protein loading, i.e. actin content was equal in samples of both genders and all 
genotypes (Fig.40 A). 
AKT phosphorylation was equal in female and male WT, IR, CC and IRCC mice. AKT protein 
content showed no differences. 
ERK1 and 2 phosphorylation was unaltered in female and male mice of all genotypes. ERK1 
and 2 protein served as control and indicated equal loading.  
GSK3α/β phosphorylation was similar in female and male WT and CC mice and slightly 
higher in female and male IR and IRCC mice. GSK3β protein amount as control of protein 
loading was unchanged (Fig.40 B). 
Protein content of MMP-9 was equal in all genotypes. Furthermore TNFα, showed decreased 
expression levels in female and male IRCC mice, whereas similar expression in female and 
male WT, IR and CC mice. Control of equal protein loading displayed to be similar  
(Fig.40 C). 
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Figure 40: InR/ IGF1R signaling pathway in female and male WT, IR, CC and IRCC mice at 3 weeks of age 
(A) IGF1R, InR and GFP expression levels are shown. Actin served as control.  
(B) Phosphorylation of AKT (pAKT, Ser473), ERK1/2 (pERK1/2, Thr202/Tyr204) and GSK3αβ (pGSK3β, Ser9) 
are shown. As control served unphosphorylated protein level of AKT, ERK1/2 and GSK3β 
(C) MMP-9 and TNFα protein expression are shown. Actin served as control. 
100 µg of total proteins were used and separated via 10% SDS-PAGE in A, B and C. 
 
 
At 3 weeks of age Fyn kinase was equally expressed in both genders and genotypes.  
Myelin specific proteins, as CNP showed a slightly reduced expression in female and male 
WT and IR mice compared to female and male CC and IRCC mice.  
MBP protein levels were similar without difference between the genotypes.  
PLP and DM20 analysis revealed a unaltered protein content in female and male mice of all 
genotypes.  
Actin protein amount as control of protein loading was unchanged (Fig.41). 
 
 
 
3. Results    
 
  77 
 
Figure 41: Myelin specific protein and Fyn kinase expression in female and male WT, IR, CC and IRCC mice at 3 
weeks of age. 
Fyn kinase, CNP, MBP and PLP expression levels are shown. Actin served as control. 100µg of total protein were 
used and separated via 10% and 15% SDS-PAGE gel. 
 
 
Analysis of InR and IGF1R signaling in the brain of 5 days old mice, showed slightly higher 
expression levels of IGF1R in female and male CC mice compared to the other genotypes.  
InR expression levels were similar in female and male mice of all genotypes. 
GFP was only detectable in female and male IRCC mice. 
Actin Western Blot showed equally loading of the gel (Fig. 42 A). 
AKT phosphorylation was unchanged in both genders of all genotypes. AKT protein levels 
showed to be the same in all tested samples. 
ERK 1 and 2 phosphorylation was unaltered in both genders of all genotypes. ERK 1 and 2 
protein level displayed no alterations in female and male mice of the four genotypes. 
Phosphorylation of GSK3α/β was similar in both genders and all genotypes. GSK3β protein 
concentration as control of protein loading was unchanged (Fig.42 B). 
MMP-9 levels were shown to be equal in female and male WT, IRCC and male CC mice, in 
contrast lower in female and male IR and female CC mice. 
Furthermore TNFα, showed similar expression levels in female and male of the four 
genotypes. 
Western Blot using actin antibodies proofed equal loading (Fig.42 C). 
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Figure 42: InR/ IGF1R signaling pathway in female and male WT, IR, CC and IRCC mice at 5 days of age 
(A) IGF1R, InR and GFP expression levels are shown. Actin served as control.  
(B) Phosphorylation of AKT (pAKT, Ser473), ERK1/2 (pERK1/2, Thr202/Tyr204) and GSK3αβ (pGSK3β, Ser9) 
are shown. As control served unphosphorylated protein level of AKT, ERK1/2 and GSK3β 
(C) MMP-9 and TNFα protein expression are shown. Actin served as control. 
100 µg of total proteins were used and separated via 10% SDS-PAGE in A, B and C. 
 
 
Fyn kinase protein expression levels were similar in female and male WT, CC and IRCC 
mice and slightly lower in both genders of IR mice. 
CNP protein expression was equal in both genders of the different genotypes. 
There were no differences in MBP expression depending on the genotypes. 
PLP and DM20 protein expression levels were equal in female and male mice of the four 
genotypes.  
Actin Western Blot, as control of protein loading revealed equal loading (Fig. 43). 
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Figure 43: Myelin specific protein and Fyn kinase expression in female and male WT, IR, CC and IRCC mice at 5 
days of age. 
Fyn kinase, CNP, MBP and PLP expression levels are shown. Actin served as control. 100µg of total protein were 
used and separated via 10% and 15% SDS-PAGE gel. 
 
 
Phosphorylation of β-Cat, β-Cat and Wnt5a protein expression showed no differences 
depending on genotype. 
Actin protein concentration revealed equal loading (Fig. 44). 
 
 
Figure 44: Wnt signaling pathway in female and male WT, IR, CC and IRCC mice at 5 days of age. 
Phosphorylation of β-Catenin (p-β-Cat, Ser33, Ser 37 and Thr41), β-Catenin and Wnt5a protein levels are shown. 
Actin served as control. 100µg of total protein were used and separated via 10% SDS-PAGE gel. 
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3.2.6. Inflammatory analysis of IRCC mice 
 
The protein expression of inflammatory proteins determined by Western Blot analysis 
revealed slightly different expression of TNFα and MMP-9 in the different genotypes. 
Therefore immunohistochemical analysis of perfused brains of female and male WT and 
IRCC mice were done. The different inflammatory cells were detected using 
immunohistochemistry in the brains of 12 and 8 weeks old mice. 
GFAP staining was more intensed in IRCC mice compared to WT mice. However staining 
intensity was stronger at 8 than in 12 weeks old IRCC mice. In WT mice only weak GFAP 
staining was detected in white and grey matter of 12 and 8 weeks old mice. 
However, all genotypes showed, as expected strong GFAP staining around the vessels and  
at brain surfaces (Fig.45). 
 
Fig 45: Immunohistochemical staining using GFAP antibodies of week 12 and 8 mice 
Perfused brains were sliced 20µm coronoally. Those were stained using antibodies against GFAP (1:200), a 
common astrocyte marker and DAPI (1:1000), which stains cell nuclei. Shown are brain slices of male WT and 
IRCC mice focused onto the corpus callosum.  
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In addition to the analysis of astrocyte expression other inflammatory cells, as macrophages 
and T-Cells were investigated in perfused brains of 12 week old male and female WT and 
IRCC mice. Furthermore, NG2 cells, which are a new class of glial cells, known to be able to 
differentiate in oligodendrocytes as well as neurons, where probed. 
Macrophage staining revealed in WT and IRCC mice no differences. In both mice brains 
resting and differentiating macrophages were detected, but as expected in low numbers. 
NG2 staining displayed no visible NG2 cell in both genotypes in the areas inverstigated. 
T-cell staining showed nearly no detectable T-cell in the brain of WT and IRCC mice (Fig.46). 
 
 
Figure 46: Immunohistochemical staining of macrophages, NG2-cells and T-cell in 12 week old WT and IRCC 
mice 
Perfused brains were sliced 20µm coronoally. Those were stained with antibodies against MAC- 2 (1:100), a 
common macrophage marker, PDGFR-α, a NG2-cell marker (1:50), CD-3 antibody, a T-cell marker (1:100) and 
DAPI (1:1000), which stains cell nuclei. Shown are brain slices of male WT and IRCC mice focused onto the 
corpus callosum. 
 
 
3.3. In vitro analysis of stably over expressing IRS-1 and IRS-2 OLN-93 cells 
 
For in vitro studies the permanent cell line (OLN-93), derived from spontaneously 
transformed cells in primary rat brain glial cultures were stably transfected with pCMV-Tag-2 
B including human derived IRS-1 and pCMV-Tag 2C mouse derived IRS-2. Vectors were 
linearized and then transfected into the OLN-93 cells. 2 days after transfection cells were 
selected with G418. Single cell clones were grown and tested for target expression. For all 
experiments 2 clones of each IRS cell line (IRS-1, 1+; IRS-2, 2+) were used. Wild-type (OLN) 
cells and cells transfected with the empty vector (EV) served as controls. Cell lines were 
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analysed in respect to changes in morphology, proliferation, IR/IGF1R signaling as well as 
expression of myelin proteins.  
 
3.3.1. Over expressing IRS-1 and IRS-2 OLN-93 cells 
 
ONL-93 cells were tested for stably transfection of pCMV-Tag-2 B (EV) , pCMV-Tag-2 B IRS-
1 (1+) and pCMV-Tag 2C IRS-2 (2+) via PCR (Fig. 47 A and B). The T7 Primers bind onto 
the pCMV sequence and result in a 250kb DNA product. The EV, the IRS-1 and IRS-2 over 
expressing ONL-93 cells displayed the pCMV specific 250kb DNA product.  
The proof of over expression was performed via Western Blot analysis. 1+ and 2+ cells 
presented a strong IRS-1 (Fig. 47 C) and IRS-2 (Fig. 47 D) protein expression signal.  
Western Blot for actin proofed equal loading (Fig. 47 C and D). 
 
 
 
Figure 47: Detection of stably over expressing IRS-1 and IRS-2 OLN-93 cells 
(A) T7 Primers specific PCR separated on a 2% agarose gel (2.9.3.). The pCMV fragment shows a size of about 
250bp, whereas untransfected cells display no PCR product. 
(B) Western-Blot detection of IRS-1 in 400µg whole cell lysate shows an elevated expression of IRS1 in stably 
transfected cells and basal protein content in untransfected (OLN) and stably transfected with pCMV-Tag-2 B 
(EV) separated on a 10% SDS-PAGE gel. 
(C) T7 Primer specific PCR separated on a 2% agarose gel (2.9.3.). The pCMV fragment shows a size of about 
250bp, whereas untransfected cells display no PCR product. 
(D) Western-Blot detection of IRS-2 in 400µg whole cell lysate shows an elevated of IRS2 in stably transfected 
cells and basal protein content in untransfected (OLN) and stably transfected with pCMV-Tag-2 C (EV) separated 
on a 10% SDS-PAGE gel. 
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3.3.2. Morphological Characterization of stably over expressing IRS-1 and IRS-2  
OLN-93 cells 
 
OLN-93 are a permanent cell line derived from spontaneously transformed cells of primary 
rat brain glial cultures [Richter-Landsberg and Heinrich, 1996]. Those cells were analysed in 
respect to morphological changes due to IRS-1 or IRS-2 over expression. 
Undifferentiated OLN-93 (OLN) cells as well as the EV cells presented when grown in low 
density a bipolar cell body with long thin extensions (Fig.48, both pictures left panel). 
If grown under serum deprivation cell bodies displayed a globular appearance. The long thin 
extensions get longer and built up complex connections between the different cell bodies 
(Fig.48, both pictures right panel). 
 
 
 
Figure 48: Phase-contrast micrographs of differentiated and undifferentiated OLN-93 (OLN) and pCMV-2C (EV) 
cells  
Cells were cultured in FCS (10%)-containing and FCS free medium, seeded on uncoated plastic dishes and 
photographed after 1 day (undifferentiated) and 6 days (differentiated). Pictures represent 100x extension. 
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Undifferentiated IRS-1 over expressing cells (1+) (Fig.49, both pictures left panel). displayed 
the same bipolar structure as the OLN and EV cells (Fig.49, both pictures left panel) and 
showed the same thin extensions.  
Interestingly 1+ cells in the differentiated state form more complex networks compared to WT 
cells (Fig.49, both pictures right panel; Fig.48, both pictures right panel). 
 
 
 
Figure 49: Phase-contrast micrographs of differentiated and undifferentiated pCMV-Tag-2 B-IRS1 stably 
transfected cells 
Cells were cultured in FCS (10%)-containing and FCS free medium, seeded on uncoated plastic dishes and 
photographed after 1 day (undifferentiated) and 6 days (differentiated). Pictures represent 100x extension. 
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Undifferentiated IRS-2 over expressing cells (2+) (Fig.50, both pictures left panel). displayed 
the same bipolar structure as the OLN and EV cells and in contrast indicated a reduced 
ability to built up long thin extensions (Fig.48, both pictures left panel). 
When differentiated, 2+ cells showed globular cell bodies (Fig.49, both pictures right panel), 
displayed longer extensions compared to the undifferentiated 2+ cells. Those extensions in 
contrast to the OLN and EV cells were shorter and not so numerous (Fig.50, both pictures 
right panel; Fig.48, both pictures right panel). 
 
 
 
Figure 50: Phase-contrast micrographs of differentiated and undifferentiated pCMV-Tag-2 C-IRS-2 stably 
transfected cells  
Cells were cultured in FCS (10%)-containing and FCS free medium, seeded on uncoated plastic dishes and 
photographed after 1 day (undifferentiated) and 6 days (differentiated). Pictures represent 100x extension. 
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3.3.3. Proliferation of stably over expressing IRS-1 and IRS-2 OLN93 cells 
 
In order to analyse, whereas IRS-2 (2+) or IRS-1 (1+) over expression in OLN-93 cells does 
change cell proliferation, BrdU proliferation assays where performed. In addition cells were 
treated with inhibitors for either the PI3K (LY294002) and MAPK (PD98059) to elucidate the 
role of the different branches of the InR/ IGF1R signaling cascade for proliferation.  
For the proliferation assay, cells were straved for 72h to stop proliferation. Then proliferation 
was initiated with 10% FCS for 48h, inhibitors were incubated for 12h and BrdU was added 
for another 12h. As controls empty vectors (EV) and non transfected OLN-93 cells (OLN) 
were used. Proliferation was measured via BrdU incorporation. 
However, no significant difference in proliferation of 1+ and 2+ cells compared to control cells 
were detected during this experimental approach (Fig. 51). 
 
 
 
Figure 51: Proliferation of stably over expressing IRS-1 and IRS-2 OLN-93 cells 
Poliferation analysis of stably over expressing IRS-1 (yellow) and IRS-2 (green) OLN-93 cells performed via BrdU 
incorporation assay. Empty vector controls (EV) (red) and untransfected OLN-93 (OLN) were used as control cell 
lines. Cells were starved  (72h) and proliferation was induced by adding 10%FCS, inhibitors (20µM LY:PI3K-
inhibitor; 50µM PD: MAPK-inhibitor) were added for 12h, cells were incubated for 12h with BrdU. DMS0 was used 
as controls, as the inhibitors were solved in DMS0. 
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3.3.4. Protein expression in stably over expressing IRS-1 and IRS-2 OLN-93 cells 
 
In terms in protein expressions of the InR/ IGF1R signaling pathway in undifferentiated and 
differentiated IRS-1 (1+) and IRS-2 (2+) over expressing OLN-93, empty vector (EV) and non 
transfected OLN-93 (OLN) cells were characterized. 
Undifferentiated 1+ cells showed increased IRS-2 levels and due to IRS-1 over expression 
an elevated IRS-1 protein content in contrast to OLN and EV cells. IGF1R levels were raised 
in contrast to InR, which was reduced, compared to OLN and EV cells. Actin used as loading 
control was unchanged (Fig.52, left panel, first row). 
Differentiated 1+ cells showed decreased IRS-2 and IRS-1 protein expression compared to 
differentiated OLN and EV cells. IGF1R protein amount was elevated. InR levels were 
similar. Protein loading was controled via actin Western Blot (Fig 52, left panel, second row). 
Undifferentiated 2+ cells displayed increased IRS-2 and IRS-1 protein expression compared 
to OLN and EV cells. IGF1R protein amount was elevated and InR levels were similar 
compared to OLN and EV cells. Actin protein levels were euqal (Fig. 52, right panel, first 
row). 
Differentiated 2+ cells showed unaltered IRS-2, IRS-1, IGF1R and InR protein expression 
levels. Actin protein concentrations were similar (Fig. 52, right panel, right row). 
 
 
 
Figure 52: InR/ IGF1R signaling pathway in undifferentiated and differentiated over expressing IRS-1 and IRS-2 
OLN-93 cells 
IRS-2, IRS-1, IGF1R and InR expression levels are shown. Actin served as control. 400 µg of total proteins were 
used and separated via 10% SDS-PAGE gel. 
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Activation of the PI3K and MAPK pathway was analysed via phosphorylation of AKT, ERK1/2 
and GSK3α/β. 
Undifferentiated 1+ cells displayed an elevated AKT phosphorylation, whereas 
phosphorylation of ERK1/2 and GSK3α/β was equal compared to OLN and EV cells. Protein 
content of AKT, ERK1/2 and GSK3β showed no changes indicating identical gel loading (Fig. 
53, left panel, first row). 
Differentiated 1+ cells demonstrated similar phosphorylation of AKT, ERK1/2 and GSK3α/β 
compared to OLN and EV cells. Protein levels of AKT, ERK1/2 and GSK3β were unchanged 
(Fig. 53, left panel, second row). 
Undifferentiated 2+ cells revealed the same phosphorylation of AKT, ERK1/2 and GSK3α/β 
as OLN and EV cells. Protein levels of AKT, ERK1/2 and GSK3β were unchanged (Fig. 53, 
right panel, first row). 
Differentiated 2+ cells showed reduced phosphorylation of AKT, equal ERK1/2 and GSK3α/β 
phosphorylation. Protein expression levels of AKT, ERK1/2 and GSK3β were similar (Fig. 53, 
right panel, second row). 
 
 
 
Figure 53: Downstream signaling of the IR/ IGF1R signaling pathway in undifferentiated and differentiated over 
expressing IRS-1 and IRS-2 OLN-93 cells 
Phosphorylation of AKT (pAKT, Ser473), ERK1/2 (pERK1/2, Thr202/Tyr204) and GSK3αβ (pGSK3β, Ser9) are 
shown. As control served unphosphorylated protein level of AKT, ERK1/2 and GSK3β. Actin served as control. 
400 µg of total proteins were used and separated via 10% SDS-PAGE gel. 
 
 
3. Results    
 
  89 
Different serine kinases such as p70S6 (S6K; p70) induce a dissociation and inactivation of 
the PI3K, due to phosphorylation of the serine residues at the C-terminus of IRS-1. 
Furthermore the abunance of phosphatase and tensin homolog deleted on chromosome ten 
(PTEN) was analysed. PTEN reverses the phosphorylation of PI3,4,5P to generate PI4,5P.  
Western Blot of lysates of undifferentiated 1+ cells showed equal signals for pP70, p70, 
pPTEN and PTEN. Actin protein content was unchanged (Fig. 54, left panel, left row). 
Differentiated 1+ cell showed unchanged phosphorylation of pP70 (upper band), p70, pPTEN 
and PTEN signals comparable in all samples tested. Actin protein content was alike (Fig. 54, 
left panel, second row). 
Furthermore, undifferentiated and differentiated 2+ cells revealed similar pP70, p70, pPTEN 
and PTEN signals when compared to WT and EV cells in Western Blot analysis. Actin 
showed equal protein content (Fig. 54, right panel, first row; Fig. 54, right panel, second row). 
 
 
 
Figure 54: S6 kinase and PTEN expression in undifferentiated and differentiated over expressing IRS-1 and IRS-2 
OLN-93 cells. 
Phospho-p70 S6 kinase (Thr389), p70 S6 kinase, phospho-PTEN (Ser380/Thr382/383) and PTEN expression 
levels are shown. Actin served as control. 400 µg of total proteins were used and separated via 10% SDS-PAGE 
gel. 
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Next cell cycle arrest and apoptosis was analysed. The cell cycle inhibitor p27 is a member 
of the Cip/Kip family of CDK inhibitors and causing cell cycle arrest. To investigate whether 
apoptosis was induced cleavage of Caspase 3 was detected using Western Blots. 
Undifferentiated 1+ cells revealed elevated p27 protein levels as well as Caspase 3 (upper 
band) and cleaved Caspase 3 (lower band) compared to OLN and EV cells. Actin Western 
Blot showed equal gel loading (Fig. 55, left panel, first row). 
Differentiated 1+ cells demonstrated increased p27 and similar Caspase3, cleaved and 
uncleaved, protein expression (Fig. 55, left panel, right row). 
Undifferentiated 2+ cells displayed identical p27 and Caspase 3, cleaved and uncleaved, 
protein levels compared to OLN and EV cells. Actin protein content was equal (Fig. 55, right 
panel, first row). 
Differentiated 2+ cells revealed increased p27 and equal Caspase 3, cleaved and uncleaved, 
levels as compared to OLN and EV cells. Actin protein amount was unchanged (Fig. 55, right 
panel, second row). 
 
 
 
Figure 55: Proliferation and apoptotic protein marker expression in undifferentiated and differentiated over 
expressing IRS-1 and IRS-2 OLN-93 cells. 
p27 (proliferation) and Caspase3 (apoptotic) expression levels are shown. Actin served as control. 400 µg of total 
proteins were used and separated via 10% and 15% SDS-PAGE gel. 
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Furthermore, Wnt signaling was analysed in undifferentiated and differentiated 1+ and 2+ 
cells. 
Undifferentiated and differentiated 1+ cell displayed equal p-β-Cat and β-Cat levels, Wnt5a 
protein content was elevated in 1+ cells compared to OLN and EV cells. Actin protein content 
showed to be even (Fig. 56, left panel, first row; Fig. 56, left panel, second row). 
Undifferentiated 2+ cells showed reduced phosphorylation of β-Cat and similar β-Cat and 
Wnt5a levels compared to OLN and EV cells. Actin protein amount was unchanged (Fig. 60, 
right panel, first row). 
Differentiated 2+ cells showed equal phosphorylation of β-Cat, as well as β-Cat and Wnt5a 
levels compared to OLN and EV cells. Actin protein content was similar (Fig. 56, right panel, 
second row). 
 
 
 
Figure 56: Wnt signaling pathway protein expression in undifferentiated and differentiated over expressing IRS-1 
and IRS-2 OLN-93 cells. 
Phosphorylation of β-Catenin (p-β-Cat, Ser33, Ser 37 and Thr41), β-Catenin and Wnt5a protein levels are shown. 
Actin served as control. 400µg of total protein were used and separated via 10% SDS-PAGE gel. 
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Myelin specific and Fyn kinase protein expression was also analysed refrerring to over 
expression of IRS-1 and IRS-2. 
Undifferentiated 1+ cells had equal Fyn kinase, MBP and PLP protein levels compared to 
OLN and WT cells. CNP protein amount was elevated in 1+ cells. Actin protein content was 
similar in all samples (Fig. 57, left panel, first row). 
Differentiated 1+ cells revealed increased CNP and PLP, whereas Fyn kinase and MBP were 
unchanged. Actin protein amount was unchanged (Fig. 57, left panel, second row). 
Undifferentiated 2+ cells displayed similar protein levels of Fyn kinase, CNP, MBP and PLP. 
Actin protein content was equal (Fig. 57, right panel, first row). 
Differentiated 2+ cells showed the same abundance for Fyn kinase, MBP and PLP, whereas 
CNP level was increased compared to OLN and EV cells. Actin protein expression was 
similar in all cell types (Fig. 57, right panel, second row). 
 
 
 
Figure 57: Myelin specific protein and Fyn kinase expression in undifferentiated and differentiated over expressing 
IRS-1 and IRS-2 OLN-93 cells. 
Fyn kinase, CNP, MBP and PLP expression levels are shown. Actin served as control. 400µg of total protein were 
used and separated via 10% and 15% SDS-PAGE gel. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   93 
 
 
 
 
 
 
4.Discussion         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.Discussion    
  94 
4. Discussion 
 
Multiple sclerosis (MS) is an inflammatory demyelinating disease that attacks the brain, 
spinal cord and optic nerves in the CNS, but skips the nerve roots and nerves of the 
peripheral nervous system (PNS). Axonal loss is an unstoppable result from MS and might 
be the pathological correlate to the irreversible neurological impairment of this disease 
[Ferguson, Matyszak, Esiri and Perry, 1997; Lovas et al., 2000; McGavern et al., 2000; Trapp 
et al., 1998]. Moreover oligodendrocytes progenitors are present in the lesion of MS they are 
unable to remyelinate those regions [Scolding 1998; Wolswijk; 1995; Wolswijk; 2000]. 
IGF-I an initiator of the InR/ IGF1R-signaling cascade is an fundamental player in 
myelination, as it acts as a survival factor for oligodendrocytes as well as their OPCs [Barres 
et al., 1992; Mason et al., 2000; McMorris et al., 1986; Ye and D’Ercole, 1999] and stimulates 
the synthesis of myelin [Roth et al., 1995]. Animal studies showed that over expression of 
IGF-I heightened myelin content [Carson et al., 1993; Ye et al., 1995] and reduction strongly 
decreases myelination and the number of OPCs [Beck et al., 1995]. Human studies showed 
that recombinant human IGF-I might not alter the course of MS on its own. But it has been 
proposed that it might be useful in combination with other therapies, due to its actions on 
oligodendrocytes and remyelination [Leist et al., 2002]. 
In previous studies homozygous IRS-2 deficient (IRS-2 (-/-)) mice showed at P10 less myelin 
proteins (MBP, PLP and MOBP) in whole brain lysates but qualitatively unchanged 
myelination was observed. Therefore it was reasoned that IRS-2 is critical for appropriate 
initiation of myelination, but not for myelin maturation. Thus, IRS-1 only partly compensates 
for the loss of IRS-2 [Freude et al., 2008].  
On the other hand mice lacking the InR revealed unchanged or altered myelination, 
indicating that myelination initiation signal is mainly transduced in the InR /IGF1R signalling 
cascade via the IGF1R [Freude et al., 2008]. 
The influence of increased IRS-2 signaling on myelination in vivo is still unknown. Thus mice 
with floxed-stopp-casette-IRS-2-sequence inserted into the Rosa26 locus (IR) were crossed 
with mice expressing the CNP driven Cre recombinase (CC) to guarantee an 
oligodendrocyte-specific over expression of IRS-2 (IRCC) (Fig. 10). 
Homozygous CNP deficient (CC (-/-)) mice are known to show normal myelin assembly. 
Furthermore, the ultrastructure and physical stability are not visibly changed in these mice. 
However, the axons developed abnormal swellings and were progressively lost leading to 
premature death of these mice mostly before one year of age. Therefore, those mice might 
present a usable MS model [Lappe-Siefke et al., 2003]. 
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4.1. Oligodendrocyte specific over expression of IRS-2 in mice 
 
For oligodendrocyte specific IRS-2 expression the CNP 1 promoter driven Cre recombinase 
(CC) expressing mice were used. Only heterozygous IRS-2 transgenic (IR) and Cre 
recombinase (CC) expressing mice have been used in the present experiments. As 
described previously homozygous CC mice showed obvious behavioural impairments at four 
month of age. For instance they developed ataxia and visible hind limb impairments [Nave et 
al., 2003].  
In the present study mice over expressing IRS-2 in an oligodendrocyte specific manner, 
showed increased IRS-2 protein and eGFP protein expression in the white matter, as 
expected. Thus the IRS-2 over expression worked in vivo. 
 
4.1.2. Body weight and brain body ratio of IRCC mice 
 
Homozygous mice lacking the IGF1R in Olig1 expressing cells (IGF1Rolig (-/-)) showed a 
significant decrease (up to 92% at 1 week of age) in brain weight compared to WT. 
Furthermore homozygous IGF1R knockout mice in PLP expressing cells (IGF1RPLP (-/-)) 
demonstrated later in live a reduction in brain weight as well. However, body growth of both 
mice displayed no abnormalities [Ye et al., 2007].  
Previuos studies revealed that homozygous IRS-1 knockout mice (IRS-1 (-/-)) exhibited an 
18% reduction in brain weigth compared to WT. In those mice IRS-2 and IRS-4 compensate 
for the loss of IRS-1. As mice over expressing IGF-I and lacking IRS-1 displayed strongly 
increased myelination [Ye et al., 2002] IRS-1 was suggested to be not essential for IGF-I 
promoted oligodendrocyte development and myelination [D’Ercole et al., 2002]. Our own 
group investigated IRS-2 knockout mice and demonstrated that IRS-2 (-/-) mice displayed 
smaller brain sizes compared to WT mice. This reduction correlated to the reduction of total 
cell number and not to impaired myelination [Schubert et al., 2003]. 
Interestingly CC (-/-) showed a overall brain reduction after seven month of age [Nave et al., 
2003]. Transgenic mice expressing IGF1R under the control of the MBP promoter displayed 
larger brain size compared to WT mice [Luzi et al., 2004]. 
Body weight and body brain ratio was measured from 5 till 140 days of age to analyse 
whether changes in body weight or brain size might be influenced in the mice investigated in 
the present study. Neither female nor male IRCC or CC mice showed any significant 
changes in their BMI and body brain ratio compared to WT or IR mice. Therefore it is 
concluded that IRS-2 over expression or CNP heterozygous knockout does not influence the 
development of the brain size as well as the BMI.  
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4.1.3. Behaviour of IRCC mice 
 
Previous studies of our group using IRS-2 (-/-) mice revealed no changes of general health 
assessment and during motor coordination testing no significant differences. Therefore IRS-2 
deficiency does not have an impact on general health or motor function [Freude et al., 2008]. 
To investigate whether the oligodendrocyte specific over expression of IRS-2 (IRCC) or 
heterozygous CNP deficiency (CC) changes motor coordination Rotarod and Grip strength 
were tested at 12 weeks of age. Furthermore Trunk Curl test was performed at 40 weeks of 
age. 
There were no significant differences detected during the Rotarod test comparing female and 
male IR and CC to WT and IRCC mice. Grip strength revealed slight differences in female 
mice, with decreased strength in CC (-/-) (CC homo) and CC mice. Male mice displayed no 
differences in grip strength.  
 
Thus IRS-2 over expression in oligodendrocytes has no strong effect onto motor function in 
mice earlier in life. 
 
4.1.4. Morphological and structural brain analysis of IRCC mice 
 
IGF1R Olig (-/-) mice displayed a decreased volume of the corpus callosum and the anterior 
commissure with reduced cell density in 6 weeks old mice. Accordingly, 25 weeks old IGF1R 
PLP (-/-) mice showed a significant reduction in the corpus callosum, cell density and total 
number of cells as well [Ye et al., 2007]. 
Our own studies in IRS-2 (-/-) mice demonstrated no pathological abnormalities or dysplastic 
areas, whereas the corpus callosum and the anterior commissure were smaller compared to 
WT mice. However brains of those mice were also smaller, but did not vary in their cellular 
composition [Freude et al., 2008]. 
Nissl staining of 3,5 month old CC (-/-) mice revealed that the density of oligodendroglial 
nuclei in the corpus callosum was unchanged [Nave et al., 2003]. In mice expressing IGF1R 
under the control of the MBP promoter an elevated density of myelinated axons, as well as 
larger brain size was observed [Luzi et al., 2004]. 
 
Investigation of both genders of the four genotypes of the present study at the age of 12, 8 
and 5 weeks via Nissl staining and Klüver Barrera staining demonstrated no changes in 
morphology and structure of the brains.  
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IRS-2 over expression may therefore have no influence on the morphology of the brains up 
to 12 weeks of age. 
 
4.1.5. Immunohistochemical analysis of Myelination in IRCC mice  
 
Previous studies showed that IGF1R Olig (-/-) mice display a reduced intensity of the 
immunostaining of the myelin proteins PLP and MBP in the brain at 2 weeks of age. 
Furthermore, IGF1R PLP (-/-) mice showed decreased myelin specific proteins [Ye et al., 
2007]. 
Our own group showed reduced staining of MBP in IRS-2 (-/-) mice at day 10 of age [Freude 
et al., 2008]. 
CC (-/-) mice revealed, up to 2.5 month of age, no differences in myelin proteins, as MBP 
[Nave et al., 2003]. 
 
Immunostaining of PLP and MBP in both genders of the four genotypes demonstrated no 
difference at 12, 8 and 5 weeks of age. Hence IRS-2 over expression in our CNP 
heterozygous background seems to have no significant influence onto the structure of myelin 
up to this time point. Further investigation of time points later in live would be intersentingly to 
reveal a possible influence of IRS-2 over expression in myelin maturation. 
 
4.1.6. Quantity of myelin specific proteins in IRCC mice 
 
As immunohistochemical analysis at day 10 aged IRS-2 (-/-) mice revealed delayed MBP 
protein expression we investigated the changes of myelin composition at day 10 of age in 
these mice. Isolation of brain myelin at day 10 of age displayed no differences in the 
expression of the tested myelin specific proteins (MBP, PLP/DM20, MAG, MOBP, 
oligodendrocyte myelin glycoprotein). Therefore it was concluded that IRS-2 deficiency 
delays initiation of myelination quantitatively but does not change myelin protein composition 
at this time point of age [Freude et al., 2008].  
Investigation of both genders and all four genotypes at described in the present study 12, 8, 
5, 3 weeks and day 5 showed no obvious differences in the myelin composition. However 
IRS-2 over expression did reveal a reduced CNP protein expression at week 20 of age. 
There was an overall higher expression of the 18.5, 17 and 14kDa isoform of MBP in female 
mice of all four genotypes.  
Taken together IRS-2 over expression results in an age dependent reduction of CNP protein 
expression. But IRS-2 does not seem to function on its own. An age dependent factor, which 
includes decreased CNP expression in myelin seems to be necessary. 
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4.1.7. Investigation of protein expression in IRCC mice  
 
4.1.7.1. InR/ IGF1R signaling in IRCC mice 
 
InR/ IGF1R signaling which might contribute to altered myelination was investigated in IRS-2 
(-/-) knockout mice by our group. Those studies revealed a significant increase of IGF1R, 
IRS-1, pAKT and pERK12 protein expression at postnatal day 10. In addition 
phosphorylation of GSK3β and ERK1/2 protein levels was elevated at day 14 of age. Later 
time points revealed no changes in InR/ IGF1R signaling. Furthermore, mice lacking the InR 
in the CNS showed no differences in myelin specific protein expression, as well as in 
downstream signaling of InR/ IGF1R during early postnatal development. Therefore initiation 
of myelination in the CNS is mediated via IGF1R/ IRS-2 regulated signals and seems to be 
independent of InR signaling. 
Hence, upregulation of IGF1R signal transduction could be a mechanism to overcome the 
loss of IRS-2 to provide proper myelination [Freude et al., 2008]. 
 
Investigation of both genders of the four genotypes at the time points week 20, 12, 8, 5, 3 
and additionally day 5 of age were therefore made in respect to InR/ IGF1R signaling. 
Whole brain lysates of 20, 3 weeks and 5 days old mice revealed no significant differences in 
InR/ IGF1R signaling.  
12 weeks old IRCC mice displayed a reduced IGF1R protein expression in both genders and 
elevated GSK3α phosphorylation at this time point. Comparing protein expression of 8 and 5 
weeks old IRCC mice a similar decreased InR protein expression was found. Downstream of 
the InR/IGF1R CC and IRCC mice show the same elevated levels of phosphorylated AKT 
and reduction of ERK signals at this time point.  
 
In contrast to IRS-2 (-/-) mice, IRS-2 over expression results not in an early developmental 
phenotype, but shows transient changes in InR protein expression between week 5 and 8 of 
age. The decrease of InR expression is accompanied by with elevated levels of pAKT and 
pERK. This might be a compensatory mechanism similar to that observed in IRS-2 (-/-) mice. 
 
4.1.7.2. Inflammatory protein expression in IRCC mice 
 
IGF1R Olig (-/-) and IGF1R PLP (-/-) mice displayed a significant increase of astrocytes in the 
corpus callosum, respectively in 2 week and 6 week old mice [Ye et al., 2007]. 
Furthermore the corpus callosum and the anterior commissure were smaller in IRS2 (-/-) mice 
compared to WT mice, but the cell density was not different. Additionally, investigation of 
4.Discussion    
  99 
astrocytes revealed no differences of GFAP staining in 8 weeks old mice. Therefore an 
inflammatory process in IRS2 (-/-) was excluded [Freude et al., 2008]. 
It has been shown that the loss of CNP results in a progressive reduction of white matter 
tracts, which accounts for the loss of brain tissue in CNP (-/-) mice aged 3.5 month and older. 
However neuronal cell death is not a feature in those mutant mice [Nave et al., 2003]. 
As CNP (-/-) mice display axonal loss during aging an inflammatory process due to this 
axonal loss might play a role in the present mouse models. Therefore CC mice might show 
increased levels of MMP-9, prior to histological and morphological changes [Svejgaard et al., 
2000]. 
TNFα is known to mediate serine phosphorylation of IRS proteins to attenuate insulin 
receptor signalling [Shier et al., 1989]. Therefore whole brain lysates of all four mutant mice 
were as well investigated for TNFα and MMP-9 expression. 
 
IRCC mice showed at 3 weeks an elevated, at 5 weeks reduced, at 12 and at 20 weeks of 
age an increased TNFα protein expression. MMP-9 protein levels were higher at 3 weeks, at 
5 weeks decreased, at 12 weeks increased and at 20 weeks again reduced.  
Those transient protein expression patterns might be a developmental phenotype of IRS-2 
over expression, compenstating for abnormal high IRS-2 levels and for decreased CNP 
levels. As CC mice showed only reduced protein expression of TNFα at 5, 8 and 12 weeks of 
age, whereas there was a reduction of MMP-9 at week 12. 
 
These transient effect does not seem to correlate with the activity InR/ IGF1R signaling 
cascade as, there were no chanages of proteins or phosphorylation of the InR/ IGF1R 
signaling cascade visible at those time points. 
 
4.1.7.3. Myelin specific protein expression in IRCC mice 
 
IGF1R Olig (-/-) as well as IGF1R PLP (-/-) mice displayed at 6 weeks of age a significant 
reduction of MBP and CNP. Therefore a functional IGF1R is necessary for a proper 
myelination [Ye et al., 2007]. Our own group could has shown in IRS-2 (-/-) mice that delayed 
inititation of myelination is due to the lack of IRS-2 [Freude et al., 2008]. CC (-/-) mice 
displayed a slight elevation of MBP in whole brain lysate, but not in purified myelin. Whereas 
PLP showed no developmental change. Hence no significant signs of dysmyelination was 
found [Nave et al., 2003]. 
 
In the present study the reduction of Fyn kinase protein expression seems to be reduced by 
IRS-2 over expression in CC mice at least, as week 5 and 8 of age display. It is known for 
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Fyn deficient mice [Yamamoto et al., 1994] that decreaseed of MBP levels correlates with 
reduced Fyn kinase abundance. Therefore it was concluded, that Fyn kinase is involved in 
the myelination process [Chao et al., 1999; Werner et al., 2009] and induces MBP protein 
expression when activated [Werner et al., 2009]. 
IRS-2 is somehow influencing protein expression of CNP in CC mice, as IRCC mice do have 
lower levels of CNP compared to CC mice at least in isolated myelin in 20 weeks old mice. 
Therefore IRS-2 seems to be one of the factors that might negatively regulate CNP protein 
expression during later myelination processes or myelin maturation.  
IRS-2 (-/-) mice displayed reduced PLP in mice younger than 3 weeks of age and normal 
protein levels in older mice. This phenotype is exactly the opposite in IRCC mice, as week 5 
old mice show increased, week 8 decreased and older than 8 weeks old unchanged levels. 
Hence it might be that IRS-2 over expression or Fyn kinase reduction is not promoting 
normal PLP and DM20 protein expression during myelination. However, it has been shown in 
cancer cells that the Ras/PI3K/Akt pathway is a mediator of Fyn kinase activation [Yadav and 
Denning, 2011]. As AKT phosphorylation is elevated in IRCC mice at 5 weeks of age, this 
increased AKT signals might lead to more phosphorylated Fyn reducing the amount of the 
active form.  
 
Taken together the transient changes in protein expression of the Fyn kinase and the slight 
transient alteration in myelin specific proteins, as CNP and PLP/ DM20 in IRCC mice might 
point to an effect of IRS-2 during development, but it seems to be rapidly conter regulated. 
As the effects were minor, it seems that IRS-2 acts or is regulated by other co-factors. 
 
4.1.7.4. Wnt-signaling in IRCC mice 
 
Previous work of our group showed that IRS-2 (-/-) mice up-regulate the IGF1R signaling 
pathway to overcome the lack of IRS-2. Between 10-14 days of age an increase of GSK3β 
protein expression was found [Freunde et al., 2008]. GSK3β is known to regulate β-catenin 
variety [Romanelli et al., 2007]. A lack of β-catenin expression results in reduced brain 
growth [Machon et al., 2003; Schuller and Rowitch, 2007]. Elevated levels of β-catenin might 
be regulated via IGF-I and its stimulation of the PI3K/Akt pathway. In addition suppression of 
GSK3β elevates IGF-I induced activation of β-catenin [D’Ercole et al., 2010]. 
In neurons it has been shown that GSK3 is regulated via Wnt3a. Although that the Wnt and 
insulin signalling cascades are largely independent (both can use non-GSK dependent 
pathways) some degree of crossover occurs, which is not dependent on Akt [Lovestone et 
al., 2011]. It is known that dysregulation of Wnt signaling contributes to failure of 
remyelination, both in mice and humans [Fancy et al., 2009; Rosenberg and Chan, 2009] as 
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Wnt/ β-catenin signaling influences expression of myelin genes and myelin sheath 
compaction [Massad et al., 2011]. 
 
Analysis of brain lysates of all four genotypes revealed no clear differences of Wnt5a, β-
catenin and p- β-catenin protein expression. 
 
As there was no correlation between IRS-2 over expression, AKT or serine phosphorylation 
of GSK3β, over expression of IRS-2 seems not to correlate with phosphorylation of GSK3 
influencing the Wnt/ β-catenin signaling pathway at all time points investigated. 
 
4.1.8. Inflammation in IRCC mice 
 
As described in 4.1.7.2 an inflammatory process might play a role in the IRCC and CC mice. 
To further analyse this point imunohistochemical analysis were performed. 
 
IRCC showed a stronger GFAP signal and a higher number of activated of astrocytes in the 
brain compared to WT. This effect was age dependent as 12 weeks old mice displayed less 
GFAP staining than 8 weeks old mice.  
 
IRS-2 over expression in oligodendrocytes might alter the outer myelin membrane leading to 
the activation of astrcocytes. Future lines of research might be directed to further investigate 
the molecular mechanism leading to this transient astroctytosis. 
Interestingly the activation of astrocytes in IRCC mice does not correlate with the activity of 
the InR/ IGF1R signaling cascade. 
 
Furthermore the data abtained by Western Blot and via Immunohistochemistry did not show 
constant increased inflammation due to IRS-2 over expression in oligodendrocytes. Thus the 
transient effects observed might be results of IRS-2 over expression but the phenomenom 
gets rapidly compensated. 
 
4.2. IRS-1 and IRS-2 over expressing OLN-93 cells 
 
In the present study stably over expressing IRS-1 (1+) and IRS-2 (2+) OLN-93 cells were 
designed and analysed. ONL-93 cells were stably transfected with pCMV-Tag-2 B (EV) , 
pCMV-Tag-2 B IRS-1 (1+) and pCMV-Tag 2C IRS-2 (2+). Both IRS constructs were under 
the control of the pCMV promoter, which guaranties a strong over expression of the 
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particular genes. Both cell lines showed IRS-1 and respectively IRS-2 protein over 
expression, as expected. 
 
4.2.1. Morphological analysis of undifferentiated and differentiated IRS-1 and IRS-2 
over expressing OLN-93 cells 
 
The spontaneously transformed cell line of primary rat brain glial cultures (OLN-93) was first 
described morphologically by Richter-Landsberg and Heinrich (1996). Undifferentiated cells 
show a bipolar cell body with long extensions, whereas differentiated cells display a globular 
appearance and long thin extensions and built up more connections between the different 
cell bodies. 
 
Since IRS-1 is not essential in IGF-I promotion of oligodendrocyte development and 
myelination [D’Ercole ett al., 2002] we investigated those cells in respect of IRS-1 and IRS-2 
over expression. 
IRS-1 over expression of IRS-1 in OLN-93 cells did not change morphology. However in 
differentiated state those cells show more thin extensions. Therefore IRS-1 over expression 
might promote differentiation. 
Our group has shown that IGF1R/ IRS-2 mediated signals are important for the correct timing 
of myelination in mice [Freude et al., 2008]. 
IRS-2 over expression in OLN-93 showed in the undifferentiated state reduced extensions, 
which was even more promoted when differentiated, suggesting that IRS-2 might inhibit 
differentiation at least in vitro. 
 
4.2.2. Proliferation of stably over expressing IRS-1 and IRS-2 OLN93 cells 
 
The proliferation assays did not give clear results, BrdU incorporation assays suggested, that 
IRS-1 over expression results in similar proliferation compared to WT.  
 
However it might be that the starvation prior to the BrdU incubation causes differentiation of 
the OLN-93 cells and that the differentiation inhibits proliferation. 
This could explain that even under condition of inhibition of the PI3K and the MAPK-kinase 
pathway the differences to just DMSO treated cells were minor. 
Similar results were obtained for IRS-2 over expressing cells which had to be similary 
discussed as well. 
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4.2.3.1. Protein expression of the InR/ IGF1R signaling pathway in stably over 
expressing IRS-1 and IRS-2 OLN93 cells 
 
The OLN-93 cell line shows morphological features as well as antigenic properties of 5- to 10 
day old rat brain oligodendrocytes [Richter-Landsberg and Heinrich, 1996]. Therefore these 
cells have similar protein expression as isolated oligodendrocytes. Little is known about 
expression of proteins of the InR/ IGF1R signaling pathway in oligodendrocytes precursors 
and OLN-93 cells.  
Over expression of IRS-1 in undifferentiated 1+ cells results in a equally elevated IRS-2 
protein expression, which are both down regulated during differentiation. IGF1R protein 
amount was elevated due to IRS-1 over expression in undifferentiated as well as in 
differentiated status. Whereas the InR protein content is reduced in undifferentiated 1+ cells 
and of the same level as in WT when differentiated. Phosphorylation of AKT was increased 
in undifferentiated cells. 
IRS-1 over expression in undifferentiated oligodendrocytes resulted in a reduction of IRS 
proteins during differentiation. IRS-1 was capable of stimulation IGF1R expression in 
undifferentiated as well as differentiated cells, whereas the InR protein amount and AKT 
phosphorylation were only influenced in the undifferentiated status via IRS-1. 
 
IRS-2 over expression revealed the same characteristics in undifferentiated cells as 
undifferentiated 1+ cells. Hence when one IRS protein is over expressed the other is equally 
increased. But in contrast to 1+ cells, differentiated 2+ cells down regulated IRS-1 and IRS-2 
concentrations to WT levels. Furthermore, undifferentiated 2+ cells revealed a higher IGF1R 
protein content, as 1+ cells. But this was lost during differentiation. Those elevated IGF1R 
levels seem to correlate with IRS-1 content. Interestingly, higher IRS-2 protein content leads 
at least in the differentiated status to a reduction of phosphorylated AKT. 
 
Thus, IRS-1 over expression leads to complex changes within the InR/IGF1R signaling 
cascade. However, when differentiated signaling is nearly unaltered. IRS-2 over expression 
leads to elevated IGF1R and reduced phosphorylation levels of AKT, but those changes 
were lost during differentiation. Furthermore, elevated IGF1R level seem to be more 
correlated to IRS-1 than IRS-2. 
 
There are several possibilities how IRS proteins many be downregulated during 
differentiation including e.g. degradation or silencing of the promoter. This interesting point 
needs further investigation 
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4.2.3.2. Downstream signaling of the InR/ IGF1R signaling pathway in stably over 
expressing IRS-1 and IRS-2 OLN93 cells 
 
It is known, that deletion of PTEN results in over activation of AKT as well as downstream 
targets like mTOR. Transgenic mice with forced expression of activated AKT in 
oligodendrocytes develop significant hypermyelination [Flores et al., 2008] possibly through a 
mTOR dependent mechanism [Macklin et al., 2009]. Therefore a therapeutic benefit of PI3K/ 
mTOR pathway activation to increase myelination was suggested. Furthermore, PTEN is an 
essential player in regulation of myelin sheath thickness as well as axon and myelin integrity. 
In contrast no exclusive function of PTEN was found during remyelination in oliodendrocytes 
[Rowitch et al., 2010]. As the S6 kinase is a direct target of mTOR it might play an important 
role during this regulatory process [Fenton and Gout, 2011; Rowitch et al., 2010].  
 
In 1+ and 2+ cells, differentiated as well as undifferentiated, no alteration in the protein 
expression of PTEN and S6 kinase was observed. This suggests that IRS-1 and IRS-2 over 
expression in OLN-93 cells does not result in constant downstream differences in the PI3K/ 
mTOR pathway. During differentiation a so far unkown regulatory mechanisms compensate 
for a possible over-activation of this pathway.  
 
4.2.3.3. Proliferation and apoptotic protein marker expression in stably over 
expressing IRS-1 and IRS-2 OLN93 cells 
 
IGF-I knockout mice displayed reduced numbers of oligodendrocytes and OPCs [Ye et al., 
2002]. Furthermore IRS-2 (-/-) mice showed a reduced brain size which emerges from a 
reduction of total cell number [Schubert et al., 2003].  
 
1+ cells showed to have elevated p27 protein levels in the differentiated as well as in the 
undifferentiated status. Whereas 2+ cell displayed increased p27 protein expression only 
when differentiated. 
Protein expression of Caspase3 and cleaved Caspase 3 was raised in undifferentiated 1+ 
cells and the same level as WT when differentiated. 2+ cells did not show any differences in 
undifferentiated as well as in the differentiated status in Caspase 3 levels. 
 
In the differentiated status elevated p27 protein levels were expected, since for differentiation 
a cell cycle arrest is necessary. This was observed in 1+ and 2+ differentiated cells. 1+ cells 
had in the undifferentiated status higher p27 protein amount, which should result in a 
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reduced proliferation, which was not to be seen BrdU proliferation analysis, via BrdU 
proliferation assay. This might hint to the observation that IRS-1 induces differentiation. 
Interestingly cleaved Caspase 3 protein species are raised in 1+ cells, which should lead to 
increased apoptosis, but was not observed in 1+ cells. However, the ratio of full length 
Caspase 3 and cleaved Caspase 3 remained stable in 1+ cells. 
 
This suggests that IRS-1 might trigger initial steps of differentiation in OLN-93 cells. 
 
4.2.3.4. Wnt-signaling pathway in stably over expressing IRS-1 and IRS-2 OLN93 cells 
 
Although the Wnt and insulin signaling cascades are largely independent (both can use the 
non-GSK dependent pathway) some degree of cross over occurs, which is not dependent on 
AKT [Lovestone et al., 2011]. Therefore changes were investigated due to over expression of 
IRS-1 and IRS-2 onto the Wnt signaling cascade. 
 
1+ cells showed an increase of Wnt5a protein amount in differentiated and undifferentiated 
cells. 2+ cells demonstrated in the undifferentiated status reduced protein levels of 
phosphorylated β-Cat. However 1+ and 2+ cells did not display any changes in 
phosphorylated GSK3 protein expression. Therefore those changes seen in the Wnt 
signaling pathway do not seem to be primary events of the IRS proteins or the InR/ IGF1R 
signaling cascade.  
 
4.2.3.5. Myelin specific proteins in stably over expressing IRS-1 and IRS-2 OLN93 cells 
 
Cells did not show elevated myelin specific protein expression in the undifferentiated status. 
Both IRS proteins were able to increase the protein amount of CNP in differentiated OLN-93 
cells. Interestingly IRS-1 was also capable to elevate PLP protein content slightly. 
 
Therefore CNP protein expression seems to be regulated during differentiation via IRS-1 as 
well as IRS-2. Suggesting that both IRS proteins have the same function concerning CNP 
expression. However, IRS-1 seems to trigger differentiation in OLN-93 which might explain 
the induction of CNP in undifferentiated 1+ cells. 
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4.3 Correlation between in vivo and in vitro model 
 
The experiments using OLN-93 cells suggest that IRS-1 triggers at least to a certain extend 
differentiation of these glial cells leading to increased numbers of cell processes in 
differentiated 1+ cells and increased p27 and CNP expression in the undifferentiated state. 
Furthermore, both IRS proteins are capable to induce CNP expression in differentiated cells, 
but not MBP or PLP suggesting a selective function of IRS-proteins to induce certain myelin-
specific proteins. In contrast, the in vivo experiment using IRCC mice did not reveal any 
alterations of myelin protein composition, myelin protein expression or InR/ IGF1R signaling 
up to 12 weeks. Surprisingly, at 20 weeks of age the CNP abundance in myelin was reduced 
in IRCC mice but not in whole brain lysates suggesting, that the subcellular distribution of 
CNP is regulated via IRS-2 in vivo. However, the CNP distribution seems not to be regulated 
via IRS-2 exclusively but seems to be dependent on an age-dependent factor since 
decreased myelin CNP was observed only in animals over 12 weeks of age. Therefore, 
investigations to elucidate the role of IRS-2 in oligodendrocytes for myelin maturation and 
remyelination are interesting fields of future research. Moreover, neither IRS protein over 
expression in OLN-93 cells nor oligodendrocyte specific over expression of IRS-2 in mice did 
cause visible changes of the InR/ IGF1R signaling cascade suggesting that alterations of this 
signaling cascade gets rapidly compensated. The slight differences in InR/ IGF1R signaling 
observed in IRCC mice and the complex changes found in OLN-93 protein (e.g. IGF1R, InR) 
might just be a phenomenon to ensure and adjust proper downstream InR/ IGF1R signaling. 
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Myelin development and maturation are fundamental processes which enables rapid and 
coordinated movement. Several human diseases have been shown to affect myelin itself or 
myelin development. The most frequent disease involving myelin is multiple sclerosis (MS). 
Multiple sclerosis is an inflammatory demyelinating disease that attacks the brain, spinal cord 
and the optic nerves in the CNS. Axonal loss might be the pathological correlate for the 
irreversible neurological impairment of this disease. The Insulin receptor (InR)/ Insulin-like 
growth factor 1 (IGFI) receptor signaling cascade is an important player during myelination, 
as it acts as a survival factor for oligodendrocytes as well as their precursors (OPCs) and 
stimulates the synthesis of myelin. Animal studies showed that over expression of IGF-I 
increases myelin content and IGF-1 deletion strongly decreases myelination and the number 
of OPCs. The insulin receptor substrates (IRS) mediate insulin’s and IGF-I’s intracellular 
effects. The IRS protein family consist at least of 4 members, IRS-1 to 4. IRS-1 and 2 are 
expressed throughout the brain. Studies of our group showed that IRS-2 is critical for 
appropriate initiation of myelination, but not for myelin maturation. However, the influence of 
increased IRS-2 signaling on myelination is still unknown. Thus, stably IRS-1 or IRS-2 over 
expressing ONL-93 cells (oligodendrocyte-like cell line) were generated and analysed. 
Furthermore, mice with inserted floxed-stop-cassette IRS-2 into the Rosa26 locus (IR) were 
crossed with mice expressing the CNP driven Cre recombinase (CC) to induce an 
oligodendrocyte specific over expression of IRS-2 (IRCC). The different genotypes were 
analysed from day 5 up to 20 weeks of age. Interestingly, IRS-1 in OLN-93 cells triggers 
differentiation of these glial cells leading to increased numbers of cell processes in IRS-1 
over expressing cells, increased p27 and CNP expression even in the undifferentiated state. 
Furthermore, both IRS proteins are capable to induce cnp expression in differentiated  
OLN-93 cells. In contrast, in vivo experiment using IRCC mice did not reveal any alterations 
of brain development, myelin protein composition, myelin protein expression, motor 
coordination or InR/IGF-1R signaling up to 12 weeks. Surprisingly, at 20 weeks of age the 
CNP abundance in isolated myelin was even reduced in IRCC mice but not in whole brain 
lysates, suggesting that the subcellular distribution of CNP is regulated via IRS-2 in vivo. 
Interestingly IRS-protein over expression in ONL93 cells or oligodendrocyte-specific IRS-2 
over expression in mice did only cause minor changes of the InR/IGF-1R signaling cascade 
suggesting that alterations of this signaling cascade gets rapidly compensated. Thus, the 
present study revealed that i) IRS-1 and IRS-2 induces expression of CNP in OLN-93 cells, 
ii) IRS-1 triggers OLN-93 cell differentiation, iii) oligodendrocyte specific over expression of 
IRS-2 does not alter myelin development but influences CNP subcellular distribution after 
myelin development is completed. 
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Myelin Entwicklung und Erhalt sind fundamentale Prozesse, welche schnelle und 
koordinierte Bewegungen ermöglichen. Verschiedene Krankheiten des Menschen sind 
bekannt dafür, dass sie Myelin oder dessen Entwicklung beeinträchtigen. Die häufigste 
Krankheit in Bezug auf Myelin ist dabei Multiple Sklerose (MS). MS ist eine entzündliche 
demyelinisierende Krankheit die, das Gehirn, das Rückenmarkt und den Sehnerv angreift. 
Verlust der Axone könnte das pathologische Korrelat für die unumkehrbare neurologische 
Beeinträchtigung bei dieser Erkrankung sein. Die Insulinrezeptor (InR)/ Insulin ähnliche 
Wachstumsfaktor I (IGFI) Rezeptor Signalkaskade ist ein wichtiger Faktor während der 
Myelinisierung. Da diese als Überlebensfaktor für Oligodendrozyten und deren 
Vorläuferzellen (OPCs) gilt und die Synthese von Myelin stimuliert. Tierstudien haben 
gezeigt, dass eine Überexpression von IGF-I zu einem erhöhten Myelin Anteil führt und eine 
Deletion zu einer drastischen Verringerung des Myelins und der Anzahl der OPCs. Die 
Insulin Rezeptor Substrate (IRS) leiten intrazellulär die von Insulin und IGF-I ausgelösten 
Effekte weiter. Die IRS Proteinfamilie besteht aus mindestens 4 Mitgliedern, IRS-1 bis 4. 
IRS-1 und 2 wereden im ganzen Gehirn exprimiert. Unsere Gruppe konnte zeigen, dass IRS-
2 ein wichtiger Faktor für die richtige Einleitung der Myelinisierung ist. Dennoch ist der 
Einfluss von erhötem IRS-2 Signal auf die Myelinisierung immer noch unbekannt. Daher 
wurden stabil transfizierte OLN-93 (eine Oligodendrozyten Zelllinie) Zellen die IRS-1 und 
IRS-2 überexprimieren generiert und analysiert. Ebenso wurden Mäuse, welche eine in das 
Rosa26 Gen eingefügte Flox-Stop-Kasette mit IRS-2 (IR) tragen, mit Mäusen gekreuzt, 
welche die Cre Rekombinase unter der Kontrolle des CNP Promotors (CC) exprimieren. Dies 
sollte eine oligodendrozyten spezifische Überexpression von IRS-2 (IRCC) gewährleisten. 
Die verschiedenen Genotypen wurden im Alter von 5 Tagen bis 20 Wochen analysiert. 
Interessanter Weise löst IRS-1 in den OLN-93 Zellen die Differenzierung dieser Gliazellen 
aus und führt zu einer Vermehrung von Zellfortsätzen in IRS-1 überexprimierenden Zellen, 
sowie erhöhte p27 und CNP Proteinexpression im undifferenziertem Zustand. Ferner sind 
beide IRS Proteine fähig in differenzierten OLN-93 Zellen die CNP Expression zu indizieren. 
Im Gegensatz, zeigte das in vivo Experiment mit IRCC Mäusen keine erkennbaren 
Unterschiede in der Entwicklung des Gehirnes, in der Proteinzusammensetzung des 
Myelins, der Expression der Myelin Proteine, in der Motorkoordination oder in der InR/IGF1R 
Signalkaskade bis zum Alter von 12 Wochen. 
Erstaunlicher Weise war die Menge an CNP in Woche 20 in isoliertem Myelin von IRCC 
Mäusen verringert, dies war aber nicht in Ganzhirnlysaten der Fall. Dies lässt schlussfolgern, 
dass in vivo die subzelluläre Verteilung von CNP durch IRS-2 reguliert werden könnte. 
Interessanter Weise führt eine Überexpression von IRS Proteinen in OLN-93 Zellen oder bei 
der Oligodendrozyten spezifischen IRS-2 Überexpression in Mäusen nur zu kleineren 
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Unterschieden in der InR/ IGF1R Signalksakade. Dies lässt darauf schliessen, das die 
Veränderungen in der Signalkaskade schnell kompensiert werden.  
Zusammengefasst zeigte diese Studie, dass i) IRS-1 und IRS-2 die Expression von CNP in 
OLN-93 Zellen induzieren kann, ii) IRS-2 die Differenzierung in OLN-93 Zellen einleiten 
kann, iii) die Oligodendrozyten spezifische Überexprimierung von IRS-2 in vivo nicht die 
Entwicklung des Myelins beeinträchtigt, aber nachdem die Entwicklung des Myelins 
abgeschlossen ist, die subzelluläre Verteilung von CNP beinflusst. 
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